
==== Front
EXCLI J
EXCLI J
EXCLI J
EXCLI Journal
1611-2156
Leibniz Research Centre for Working Environment and Human Factors

2024-7475
10.17179/excli2024-7475
Doc991
Review Article
Deciphering NF-kappaB pathways in smoking-related lung carcinogenesis
Thapa Riya 1
Moglad Ehssan 2
Goyal Ahsas 3
Bhat Asif Ahmad 1
Almalki Waleed Hassan 4
Kazmi Imran 5
Alzarea Sami I. 6
Ali Haider 78
Oliver Brian Gregory 910
MacLoughlin Ronan 111213
Dureja Harish 14
Singh Sachin Kumar 151617
Dua Kamal *1618
Gupta Gaurav 1920
1 Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India
2 Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia
3 Institute of Pharmaceutical Research, GLA University, Mathura, U.P., India
4 Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia
5 Department of Biochemistry, Faculty of Science, King Abdulaziz University, 21589, Jeddah, Saudi Arabia
6 Department of Pharmacology, College of Pharmacy, Jouf University, 72341, Sakaka, Al-Jouf, Saudi Arabia
7 Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India
8 Department of Pharmacology, Kyrgyz State Medical College, Bishkek, Kyrgyzstan
9 Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW 2137 Australia
10 School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007 Australia
11 Research and Development, Aerogen Limited, IDA Business Park, Galway, Connacht, H91 HE94 Ireland
12 School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Leinster, D02 YN77 Ireland
13 School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, Leinster, D02 PN40 Ireland
14 Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, Haryana, India
15 School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India
16 Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia
17 School of Medical and Life Sciences, Sunway University, Sunway City, 47500, Malaysia
18 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia
19 Center for Research Impact & Outcome-Chitkara College of Pharmacy, Chitkara University, Punjab
20 Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates
*To whom correspondence should be addressed: Kamal Dua, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia, E-mail: kamalpharmacist02@gmail.com
19 8 2024
2024
23 9911017
05 5 2024
01 7 2024
Copyright © 2024 Thapa et al.
2024
https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited.
This article is available from https://www.excli.de/vol23/excli2024-7475.pdf
One of the main causes of death worldwide is lung cancer, which is largely caused by cigarette smoking. The crucial transcription factor NF-κB, which controls inflammatory responses and various cellular processes, is a constitutively present cytoplasmic protein strictly regulated by inhibitors like IκB proteins. Upon activation by external stimuli, it undergoes phosphorylation, translocates into the nucleus, and modulates the expression of specific genes. The incontrovertible association between pulmonary malignancy and tobacco consumption underscores and highlights a public health concern. Polycyclic aromatic hydrocarbons and nitrosamines, potent carcinogenic compounds present in the aerosol emitted from combusted tobacco, elicit profound deleterious effects upon inhalation, resulting in severe perturbation of pulmonary tissue integrity. The pathogenesis of smoking-induced lung cancer encompasses an intricate process wherein NF-κB activation plays a pivotal role, triggered by exposure to cigarette smoke through diverse signaling pathways, including those associated with oxidative stress and pro-inflammatory cytokines. Unraveling the participation of NF-κB in smoking-induced lung cancer provides pivotal insights into molecular processes, wherein intricate crosstalk between NF-κB and pathways such as MAPK and PI3K-Akt amplifies the inflammatory response, fostering an environment conducive to the formation of lung cancer. This study reviews the critical function of NF-κB in the complex molecular pathways linked to the initiation and advancement of lung carcinogenesis as well as potential treatment targets.

See also the graphical abstract(Fig. 1).

smoking
lung cancer
NF-kappaB pathway
tumorigenesis
inflammation
therapeutic interventions
==== Body
pmcIntroduction

Lung cancer is a major cause of mortality worldwide and a major public health problem. The main cause of lung cancer, accounting for around 85 % of instances, is tobacco use, which includes using cigarettes, cigars, and pipes (de Sousa and Carvalho, 2018[46]). Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two most prevalent kinds of lung cancer; NSCLC is more common and develops more slowly, whilst SCLC is less common but frequently grows more swiftly (Dubin and Griffin, 2020[55]). Even with significant advancements in tobacco control, lung cancer will continue to be a leading cause of death globally for a number more decades, given present smoking habits (Hirsch et al., 2017[82]). Lung cancer is predicted to have killed 1.8 million people in 2020 (18 %) (Hoy et al., 2019[87]). Air pollution, asbestos and chemical exposure at work, and secondhand smoke are additional risk factors for lung cancer (Huang et al., 2023[90]). Early lung cancer symptoms might be insignificant or mistaken for other respiratory problems, delaying detection (Abubakar et al., 2023[1]; Chang et al., 2021[31]). Lung cancer caused by smoking is still one of the biggest worldwide health concerns and because of its significant effects on general health, it is imperative to fully understand the underlying molecular pathways of this disease (Dela Cruz et al., 2011[48]; Hou et al., 2019[86]). Lung cancer caused by smoking is one of the world's most common causes of cancer-related fatalities, and most instances are associated with cigarette smoking (Lee and Kazerooni, 2022[113]). The substances found in smoke from cigarettes can damage the genetic material in the lung cells, placing you at a considerably elevated risk of getting lung cancer (Balaga et al., 2023[11]; Malyla et al., 2023[132]). Even with significant advancements in tobacco control, lung cancer will continue to be a leading cause of death globally for a number more decades, given present smoking habits.

Global impact of lung cancer and its association with smoking

The enormous worldwide burden of lung cancer is a reflection of both the disease's variety and the ubiquitous effect of tobacco use (Nagah and Amer, 2021[142]). According to the World Health Organization (WHO), lung cancer accounts for around 2.1 million new cases and 1.8 million deaths worldwide each year, making up almost half of the cancer burden (Nagah et al., 2019[143]). Smoking is identified as the primary causative cause of lung cancer development due to its wide range of carcinogenic chemicals (Prijić and Igić, 2021[153]). About 85 % of cases of lung cancer are caused by smoking, which is the main avoidable risk factor for the illness. The regional distribution of lung cancer incidence is closely connected with variations in smoking prevalence among regions (Rivera and Wakelee, 2016[164]). The relationship between smoking and lung cancer is further shown by the fact that countries with greater tobacco use rates also tend to have higher incidences of lung cancer (Saba et al., 2017[167]). It is critical to comprehend this global context because it emphasizes the pressing need for comprehensive initiatives to reduce the incidence and death of lung cancer caused by smoking (Shreves et al., 2023[171]; Wang et al., 2021[193]).

NF-κB's role in the pathogenesis of smoking-induced lung cancer

The NF-κB transcription factor family is necessary for several physiological processes, such as cell survival, immune responses, and proliferation (Aswini, 2009[8]). Its involvement in cancer has been well investigated; findings indicate that dysregulation of it happens in several malignancies, including lung cancer (Chiang et al., 2023[37]). Despite its context-dependent participation in cancer and potential pro- and anti-tumorigenic properties, the precise roles played by NF-κB in smoking-induced lung cancer remain an intriguing and challenging area of investigation (Conlon et al., 2020[39]; Czyżykowski et al., 2016). Cigarette smoke contains a complex mixture of over 7,000 chemicals, which causes lung tissues to go through a sequence of reactions that lead to DNA damage, chronic inflammation, and cancer (Bao et al., 2023[12]). One important chemical event that is brought on by these events is NF-κB activation. Nevertheless, further research is necessary to determine the exact pathways by which NF-κB affects the development and course of smoking-induced lung cancer (Chiang et al., 2023[37]; Conlon et al., 2020[39]). The complicated etiology of smoking-related lung cancer includes the interplay of inherited, environmental, and lifestyle factors (Jin et al., 2021[94]). A number of carcinogens, including polycyclic aromatic hydrocarbons (PAHs), nitrosamines, and heavy metals, are present in cigarette smoke. These chemicals damage DNA, induce mutations, and alter epigenetic patterns, all of which promote the growth of cancer (Bhat et al., 2024[18]; Jomova et al., 2023[97]). Cigarette smoke not only causes genotoxicity but also chronic inflammation, which creates an environment that is conducive to the growth of cancer (Li et al., 2019[119]). The recruitment of immune cells is facilitated by inflammatory mediators such as chemokines and cytokines, which intensify the inflammatory response (Lin et al., 2021[122]). An important role for NF-κB, a master regulator of inflammation, appears in this process (Ma et al., 2020[129]). Because of its adaptability in cellular functions, NF-κB is an important participant in the intricate web of processes that are set off by exposure to cigarette smoke (Qian et al., 2022[155]). Comprehending the ways in which NF-κB influences inflammation, immunological response, and cell survival in the context of smoking-induced lung cancer is essential for the creation of focused therapeutic approaches (Bhat et al., 2023[19]; Qiu et al., 2017[156]). This review attempts to critically evaluate the molecular processes that NF-κB orchestrates in the pathogenesis of smoking-induced lung cancer, address current developments in lung cancer therapy and prevention.

NF-κB: An Overview

An essential modulator of cellular responses, NF-κB affects a wide range of physiological functions. In the realm of cancer, NF-κB is a an essential molecular conductor that directs complex signaling cascades that advance the illness (Williams and Gilmore, 2020[197]; Zhang et al., 2017[207]). When it functions properly, NF-κB is essential for immunological responses, inflammation, and cell viability (Wibisana and Okada, 2022[196]). On the other hand, smoking-related lung cancer is one type of cancer linked to abnormal NF-κB activation (Bhat et al., 2023[20]; Sun, 2011[178]). Understanding the complex involvement of NF-κB in cellular dynamics provides a crucial foundation for understanding the complexities of smoking-induced lung cancer and opens up new avenues for targeted therapeutics intended to disrupt the cascade of events orchestrated by this molecular player.

NF-κB's involvement in cancer

In an environment of cancer, NF-κB plays a dual role as an adversary and a protector at the junction of cellular destiny (DiDonato et al., 2012[50]). As a guardian of cellular survival, NF-κB orchestrates immune responses and maintains tissue homeostasis when it is operating appropriately (Eluard et al., 2020[58]). On the other hand, NF-κB becomes a potent cancer-spread promoter when it is activated improperly (Fan et al., 2013[60]). NF-κB performs a myriad of functions in the complicated topography of cancer. It increases chronic inflammation, promotes cell proliferation, and inhibits apoptosis, all of which help to create an environment that is conducive to tumor growth (Hoesel and Schmid, 2013[84]; Khan et al., 2020[101]). When smoking causes lung cancer, the carcinogenic components of tobacco smoke become the crucial factor that triggers NF-κB activation (Bhat et al., 2024[21]; Lalle et al., 2021[111]). Lung cancer develops, advances, and is maintained by a number of molecular pathways that are triggered and maintained by this activation (Lawrence, 2011[112]).

NF-κB activation in response to smoking-induced inflammation

It is known that inhaling tobacco smoke triggers the transcription factor NF-κB, which is essential for inflammation (Conlon et al., 2020[39]). In one study, gingival epithelial cells (Ca9-22) were treated to 10 % cigarette smoke extract (CSE) for six hours (Dang et al., 2020[43]). The results showed that the RAGE was significantly more expressed, and this caused the NF-κB signaling pathways to be activated (Deng et al., 2023[49]). Via quantitative PCR and immunoblotting, the enhanced RAGE expression following CSE therapy was confirmed. Moreover, the activation of Ras and additional NF-κB signaling intermediates was observed (Gonçalves et al., 2011[68]). The previously stated activation suggests that NF-κB is necessary for the cell's response to inflammation brought on by smoking (He et al., 2020[76]). Further evidence that NF-κB is active in the inflammatory cascade comes from the study's evaluation of larger levels of pro-inflammatory cytokines, such as IL-1β and IL-6 in the cell culture media of CSE-exposed cells than in controls (Hirano, 2021[80]; Huang et al., 2022[91]). Co-treatment with CSE and SAGEs effectively decreased the inflammatory responses, indicating the involvement of NF-κB in smoking-induced inflammation. These findings demonstrate the involvement of NF-κB in the molecular pathways of inflammation caused by cigarette smoke, offering insights that might aid in the development of focused therapies for oral conditions exacerbated by tobacco smoke exposure (Kunnumakkara et al., 2020[110]; Rastrick et al., 2013[160]) (Figure 2(Fig. 2)).

Mechanisms of NF-κB Activation in Smoking-Induced Lung Cancer

MARCKS pathway

Lung cancer caused by smoking is largely influenced by NF-κB. The transcription factor NF-κB, which controls the expression of genes linked to cell division, survival, and inflammation, is activated by prolonged inhalation of tobacco smoke (Rojas-Quintero et al., 2023[166]). A number of processes are triggered by this activation, which contributes to the tumor's development and dissemination (Sivandzade et al., 2019[174]). NF-κB promotes angiogenesis, prevents apoptosis, and helps cancer cells survive (Sokolova and Naumann, 2017[175]). Moreover, it sets off the production of cytokines that promote inflammation, creating an environment that is conducive to the growth of tumors (Thapa et al., 2022[187]; Walter et al., 2020[190]). Targeting NF-κB signaling pathways presents a promising avenue for therapeutic therapies in smoking-associated lung cancer by interfering with critical processes that promote oncogenesis and progression (Bhat et al., 2024[22]; Wang et al., 2019[191]). Cellular signaling and cytoskeletal regulation are mediated by a protein known as MARCKS (Wei et al., 2022[195]). It is necessary for a number of biological processes, including as cell motility, membrane trafficking, and exocytosis (Wronka et al., 2022[198]). Numerous physiological and pathological processes in cells are impacted by MARCKS's interaction with cell membranes, which is influenced by its level of phosphorylation (Li et al., 2019[119]). Liu et al. examined the function of MARCKS in lung cancer caused by smoking. It was discovered that smoking cigarettes activates MARCKS in lung cancer cells and the epithelium of the airways. The NF-κB signaling is activated as a result of this activation, and low survival and phospho-NF-κB are strongly associated. On the other hand, EMT, pro-inflammatory cytokines, and stem-like characteristics are all upregulated by phospho-MARCKS. These effects are suppressed when MPS peptide is used to target MARCKS phosphorylation (Liu et al., 2021[123]) (Figure 3(Fig. 3)).

Cell surface receptor-mediated pathways

The cell surface receptor for IGF-1 is IGF-1R. It relates to the family of receptor tyrosine kinases and is crucial for cellular growth, differentiation, and survival (Bhalla et al., 2022[17]; Geffken et al., 2022[66]). IGF-1R activation sets off a signaling cascade that controls a volume of cellular functions and aids in the growth and upkeep of tissues (Hellstrom et al., 2017[77]). IGF-1R signaling dysregulation has been linked to cancer and other illnesses (Higashi et al., 2019[78]). According to the study by Min et al., smoking-related lung carcinogenesis is connected with the activation of RTKs. The study revealed that this process requires NNK-induced activation of the β-AR, which in turn promotes the IGF-1R. NNK administration activated the IGF-1R signaling pathway, which was blocked by pharmacologic or genetic suppression of β-AR. β-AR and NF-κB agonists were shown to increase IGF-1R phosphorylation, and treating mice with β-AR antagonists prevented the development of lung cancers. In order to help smokers, avoid lung cancer, the research suggests that blocking β-AR-mediated IGF-1R activation might be an effective strategy (Min et al., 2016[139]). Tpl2 kinase is a serine-threonine kinase that is involved in inflammatory and immunological responses (Escós et al., 2022[59]). It is sometimes referred to as Cot kinase. It has a role in MAP kinase pathway activation (Bhat et al., 2023[23]; Johannessen et al., 2010[96]). A study by Sun et al. discovered that NF-κB actually has a tumor-suppressive effect. Low patient survival and elevated exposure to cancer of the lungs in people are associated with NF-κB1 downregulation. NF-κB1-deficient mice, however, are more susceptible to lung carcinogenesis brought on by urethane, a smoking carcinogen. Instead of acting as an NF-κB factor, as is the case with its traditional role, NF-κB1 suppresses tumors via stabilizing Tpl2 kinase. When it comes to lung carcinogenesis triggered by urethane, Tpl2-knockout animals are similar to NF-κB1 knockouts. The study revealed unidentified role for p105/ Tpl2 signaling in lung homeostasis and an unexpected, NF-κB-independent but Tpl2-dependent role for NF-κB1 in suppressing lung tumors (Sun et al., 2016[177]).

One cell surface receptor connected to inflammatory reactions is the RAGE (Krizan and Johar, 2015[108]). Cigarette smoke exposure raises the expression of RAGE, which exacerbates oral inflammation (Leone et al., 2021[115]). It was investigated if semi-synthetic glycosaminoglycan ethers (SAGEs) could suppress RAGE signaling. In gingival epithelial cells, co-treatment with SAGEs and cigarette smoke extract reduced inflammatory responses (MacLaren, 2015[130]). This implies that SAGEs could be useful in reducing the effects of RAGE-mediated inflammation, offering a possible path for therapeutic treatments in illnesses made worse by exposure to tobacco smoke (Rasmussen, 2015[159]). Sanders et al. examined that exposing gingival Ca9-22 to 10 % CSE for six hours increased RAGE expression and activated NF-κB and Ras signaling. Elevated IL-6 and IL-1β in the culture medium indicated inflammatory responses. SAGEs were used to block RAGE signaling, reducing inflammatory effects when co-treated with CSE. This suggests a potential therapeutic target in NF-κB-related pathways for diseases exacerbated by tobacco smoke-induced oral inflammation (Sanders et al., 2017[168]).

Genetic variants and polymorphisms

Genetic variants in the NF-κB1 gene, which codes for a subunit of the NF-κB transcription factor, are referred to as NF-κB1 polymorphisms (Aidinidou et al., 2021[3]). These differences may impact NF-κB activity, which in turn may impact inflammation and the immune system (Bhat et al., 2023[23]; Cartwright et al., 2016[30]). Among other diseases, certain SNPs have been connected to a higher chance of developing autoimmune and inflammatory disorders (Jin et al., 2019[95]). Yin et al. studied five different forms of NF-κB1, which were investigated in relation to smoking and other genes in research that included 387 Chinese controls that were cancer-free, whereas 384 patients had lung cancer. Although individual variations did not directly correlate with the risk of lung cancer, a particular haplotype did indicate a lower risk when smoking duration was taken into account. The results emphasize the importance of NF-κB and smoking in inflammation-associated lung cancer etiology and point to a possible link between NF-κB1 polymorphisms, smoking duration, and lung cancer development in the Chinese population (Yin et al., 2015[203]).

The study by Lu et al. on the effects of CSE on HBE cells also showed that CSE decreased PTEN levels while increasing the expression of miR-21, p-Akt, p-NF-κB and HIF-1α. Suppression of PTEN caused by increased miR-21 has an effect on the Akt/NF-κB pathway. Silencing of HIF-1α or NF-κB prevented CSE-induced alterations, whereas miR-21 up-regulation reversed these effects. The results uncover a new pathway that connects smoking, miR-21, HIF-1α, and NF-κB to lung carcinogenesis brought on by CSE (Lu et al., 2018[126]). Using a squamous cancer cell line as a comparison, Rohrer et al. examined the effect of CSC on NF-κB activation in HPV-transformed oral and bronchial cells. NF-κB was activated in a dose-dependent manner by all cells, while HPV-transformed cells responded more strongly. Smoking cigarettes may accelerate the NF-κB-dependent development of HPV+ premalignancy into cancer. The findings propose that future research should concentrate on NF-κB targeting during premalignancy and malignant development, especially in HPV+ individuals (Rohrer et al., 2010[165]).

While the NF-κB1 rs28362491 polymorphism is linked to altered NF-κB activity, a crucial regulator of inflammation and immunological responses, the PPP1R13L gene produces a protein implicated in apoptosis (Chen et al., 2016[34]; Guo et al., 2021[71]). Genetic differences in NF-κB1 may impact NF-κB-mediated activities, which in turn may affect susceptibility to certain illnesses (Li and Zhang, 2019[118]). Comprehending these genetic variables offers valuable perspectives on the intricate relationship between genetic alterations and cellular processes in both well-being and illness (Long et al., 2022[125]). Yin et al. evaluate the relationship between smoking duration, PPP1R13L, NF-κB1 rs28362491 polymorphism, and lung cancer risk in a Chinese population. After examining 544 instances of lung cancer and 550 age, sex, and ethnicity-matched controls, NF-κB1 rs28362491 was not associated with the risk of developing lung cancer. A higher risk was seen in the dominant model for CD3EAP rs967591. Lung cancer was linked to a common haplotype comprising CD3EAP rs967591(A), PPP1R13L rs1970764(G), and CD3EAP rs735482(C). The results of interaction studies demonstrated associations between the length of smoking and NF-κB1 rs28362491-PPP1R13L rs1970764 as well as CD3EAP rs735482, indicating participation in the same pathway that results in smoking-induced lung cancer (Yin et al., 2016[202]).

Interaction with nicotine and NNK

Cigarette Smoke Extract (CSE) is produced when cigarette smoke condenses, it is made up of a complicated mixture of substances, such as tar, nicotine, and several hazardous compounds (Cai et al., 2021[29]). In order to imitate the effects of cigarette smoke exposure on biological systems, researchers frequently utilize CSE in their studies (Fang et al., 2021[61]). This helps to identify possible therapies for smoke-induced health concerns as well as insights into the processes behind smoking-related disorders (Gellner et al., 2016[67]). Zhao et al. examined the effects of CSE on HBE cells, with particular attention to the transition between the epithelium and mesenchymal tissue (EMT) and inflammation. Exposure to CSE for an extended period of time resulted in EMT and cellular transformation, which in turn activated NF-κB and increased proinflammatory interleukin-6 (IL-6). As a result, miR-200c levels dropped. Suppressing miR-200c and boosting EMT, NF-κB and IL-6 pathways were shown to be involved in CSE-induced IL-6 elevation. The maintenance of the change produced by CSE required IL-6. The prevention of CSE-induced EMT and malignant transformation was achieved by NF-κB inhibition, revealing a connection between inflammation, EMT, and CSE-induced lung carcinogenesis (Hussain et al., 2023[92]; Zhao et al., 2013[209]).

Nicotine is a stimulant that affects the central nervous system and is extremely addictive (Bitzer et al., 2023[25]; Brown et al., 2003[28]). Tobacco smoke contains NNK, a powerful carcinogen (Ding et al., 2008[52]). The body activates NNK metabolically, which damages DNA and promotes the growth of certain malignancies, including lung cancer (Edwards et al., 2021[56]). The negative health consequences of tobacco usage are mostly caused by both nicotine and NNK (Gankhuyag et al., 2017[64]; Singla et al., 2023[173]). Tsurutani et al. examined the effects of nicotine and NNK, two tobacco constituents, on the survival and proliferation of lung cancer cells via triggering the Akt pathway. In both SCLC and NSCLC cells, nicotine and NNK quickly activated Akt. FKHR, GSK-3, mTOR, tuberin, and S6K1 were among the downstream substrates whose phosphorylation was elevated by nicotine. Different nicotinic acetylcholine receptor subunits were expressed by NSCLC cells. Akt was activated by nicotine via the alpha3/alpha4 or alpha7 subunits. In an Akt-dependent and NF-κB-dependent way, nicotine-induced proliferation and prevented apoptosis, pointing to a possible connection between smoking and the advancement of cancer (Tsurutani et al., 2005[188]). Similarly, Sugano et al. looked at how nicotine affected the inflammatory mediators that activated macrophages generated. Before LPS treatment, nicotine dramatically reduced the transcriptional levels of PGE2, IL-1, and IL-8 in U937 cells. The decrease of NF-κB, a transcription factor essential for activating these genes, was connected to the inhibition. These results imply that nicotine's inhibition of NF-κB may be a factor in the immunosuppression brought on by cigarette smoke (Sugano et al., 1998[176]).

A type of cigarette called light cigarettes (LC) is made to emit less tar and nicotine when smoked (Benowitz et al., 2017[15]). For this, manufacturers employ filters, modified tobacco mixes, or a combination of the two (Breitbarth et al., 2018[27]). Even though they are referred to be "light," smokers may make up for lower nicotine levels by taking larger puffs or smoking more cigarettes, so they are not always a safer option (Chang et al., 2021[31]; Thapa et al., 2024[180]). There are still health concerns, and regulations have been put in place to clear up misunderstandings about how little harm they actually cause (Crosbie et al., 2022[40]). Valenca et al. show that exposure to light cigarettes (LC) is thought to carry less health hazards than conventional cigarettes; nonetheless, research conducted on C57BL/6 mice showed negative consequences after 60 days of exposure to 3, 6, or 12 LC. Emphysema, an imbalance in ECM, a reduction in tissue inhibitor of metalloprotease-2, and an increase in matrix metalloprotease-12 detection were seen in the 12 LC group. Despite thoughts of less danger, the study indicates that LC may really be harmful to the lungs, altering the balance of the extracellular matrix and exacerbating emphysema. In comparison to mice exposed to ambient air, higher levels of NF-κB and TNF-alpha were also seen in the LC-exposed groups (Valenca et al., 2006[189]).

Role of specific pollutants in NF-κB activation

Sulfur-containing fossil fuels are the main source of sulphur dioxide (SO2), a colorless gas with a strong odor. It has a role in acid rain generation and air pollution (Blum et al., 2023[26]; Chen et al., 2022[36]). Inhaling SO2 can cause respiratory problems, including difficulty breathing. It is a major air pollutant that is controlled to safeguard the public's health and the environment (Guo et al., 2021[70]). Yun et al. showed at low doses, their synergistic toxicity was shown, leading to considerable impairment in cell survival and apoptosis. Similar to how NF-κB plays a role in smoking-induced lung cancer, the mechanism included the generation of ROS and the activation of NF-κB, highlighting the need of taking into account interactions between pollutants (Yun et al., 2015[204]).

COX pathways and proinflammatory mediators

The enzyme cyclooxygenase-2 (COX-2) is in charge of producing prostaglandins, which are inflammatory mediators (Bernard et al., 2008[16]). In contrast to COX-1, COX-2 is induced and frequently increased in response to stimuli that cause inflammation (Doré, 2011[53]). Because COX-2 overexpression is linked to a number of illnesses, such as cancer and inflammatory ailments, it is a target for therapeutic therapies (Frejborg et al., 2020[63]). Ratovitski et al. examined the effect of cigarette smoke on the transcriptional control of inflammatory molecules, with NF-κB being the main emphasis. When primary and secondary smoking were modeled using extracts from mainstream and sidestream smoke, it was shown that there was dose-dependent downregulation of LKB1 and overexpression of PEA3 and COX-2 proteins. Endogenous ChIP study demonstrated that NF-κB binds to the COX-2 promoter and forms compounds in lung tumor cells exposed to cigarette extracts. These findings underscore the significance of inflammation in the carcinogenesis of epithelial cells by highlighting a unique relationship between transcription factors, most notably NF-κB, and the cellular response to cigarette smoke (Ratovitski, 2010[161]). Further, Baglole et al. show that compared to wild-type (AhR(+/+)) fibroblasts, lung fibroblasts without the AhR gene (AhR(-/-)) show an increased inflammatory reaction to smoking from cigarettes, which is characterized by higher levels of prostaglandins (PGs) and COX-2. Transient transfection was used to validate AhR expression, and it showed a substantial reduction in smoke-induced COX-2 and PG production in AhR(-/-) fibroblasts, indicating the anti-inflammatory activity of AhR. Although AhR and NF-κB interact, the increased inflammatory response in AhR(-/-) fibroblasts is linked to RelB loss rather than NF-κB (p50/p65) activation. This emphasizes AhR and RelB's possible therapeutic target in treating disorders associated with inflammation (Baglole et al., 2008[9]).

Specialized immune cells called sentinel cells serve as the body's first line of defense against infections or other dangers (Daigneault et al., 2010[42]; Gupta et al., 2023[72]). Because these cells are always keeping an eye on their environment, they are essential to the immune system's surveillance (Hodge et al., 2022[83]). Sentinel cells sense foreign invaders or aberrant cells, and when they do, they trigger an immunological response that activates other immune system components to get rid of the threat and keep the body healthy overall (Marciscano and Anandasabapathy, 2021[133]; Pitt et al., 2016[151]). Martey et al. investigated the significance of fibroblasts, specifically their function as "sentinel" cells that initiate inflammation by releasing proinflammatory chemicals such as prostaglandins. Through the promotion of chronic inflammation, the overexpression of COX-2 and excessive eicosanoid synthesis, which are found in early carcinogenesis, may establish a susceptibility to cancer. When normal human lung fibroblasts are exposed to cigarette smoke, NF-κB activation-mediated prostaglandin production and COX-2 expression are elevated. This may be the first stage of epithelial transition, this persistent inflammatory condition (Martey et al., 2004[134]).

Role of Rel subtypes and alternative NF-κB pathways

RelB is a transcription factor that belongs to the NF-κB family and is involved in immune and inflammatory responses (Kim et al., 2023[103]; Millet et al., 2013[138]). RelB is not like other NF-κB proteins in that it frequently suppresses the immune system (Mockenhaupt et al., 2021[140]). It controls genes involved in immunological tolerance and the development of lymphoid organs and creates alternative NF-κB dimers (Navarro et al., 2023[144]). RelB is a possible therapeutic target for regulating immune responses since it is linked to a number of illnesses (Seet et al., 2021[169]). The function of RelB in controlling smoke-induced COX-2 protein production in pulmonary fibroblasts is examined by Zago et al. RelB deficiency reduces the production of COX-2 protein even in the presence of Cox-2 mRNA increase and activation of the NF-κB pathway. The results show that whereas RelB has no effect on mRNA stability, it does have an effect on miR-146a baseline levels. Smoking cigarettes raises miR-146a only in cells that express RelB. While inhibiting miR-146a greatly increases COX-2 protein levels, it has little effect on RelB or Cox-2 mRNA stimulation by smoke. Accordingly, it is possible that a novel pathway, the RelB-miR-146a axis, regulates inflammation in reaction to pulmonary toxicants, particularly those associated with NF-κB and smoking (Zago et al., 2014[205]).

In lung tissues, the carcinogens in CS, such as nitrosamines and polycyclic aromatic hydrocarbons, cause inflammatory reactions and genetic alterations (Armstrong et al., 2004[5]; Holme et al., 2023[85]; Thapa et al., 2023[186]). Prolonged exposure triggers the activation of oncogenic pathways, such as NF-κB, which facilitates angiogenesis, cell survival, and proliferation (Kordiak et al., 2022[105]). Furthermore, the inflammation brought on by CS fosters the growth of tumors (Moorthy et al., 2015[141]). These interrelated factors support the development and spread of lung cancer, highlighting the crucial part that cigarette smoke plays in the etiology of this fatal illness (Petit et al., 2019[150]; Singh et al., 2018[172]). Yao et al. investigate the mechanism by which lung cancer in mice is produced by CS. RelA/p65⁻/⁻ mice and WT mice were split into two groups and given either air or CS. When compared to WT mice exposed to air, CS-treated animals displayed increased lung weight, tumor multiplicity, and maximal tumor size. WT mice's longevity was markedly shortened by CS exposure, but myeloid cells with RelA/p65 deleted had a higher survival rate. Increased macrophage infiltration and higher Ki-67-positive cells were linked to CS-induced lung cancer development. According to the study, TNFα and the myeloid cell RelA/p65 are important factors in the development of lung cancer brought on by CS (Yao et al., 2014[201]) (Table 1(Tab. 1); References in Table 1: Baglole et al., 2008[9]; Jin et al., 2019[95]; Liu et al., 2021[123]; Lu et al., 2018[126]; Ma et al., 2015[128]; Majumder et al., 2021[131]; Min et al., 2016[139]; Ratovitski, 2010[161]; Rioux and Castonguay, 2000[163]; Rohrer et al., 2010[165]; Sugano et al., 1998[176]; Sun et al., 2016[177]; Valenca et al., 2006[189]; Wang et al., 2021[192]; Yin et al., 2016[202]; Yun et al., 2015[204]; Zago et al., 2014[205]; Zhang et al., 2018[208]).

Epigenetic Mechanisms in Smoking-Induced NF-κB Activation

METTL3 and m6A modification

METTL3 functions as a methyltransferase in the critical RNA regulatory process of N6-methyladenosine (m6A) modification (Chen et al., 2022[32]). On mRNA, it adds m6A markers. The m6A reader protein YTHDF2 mediates the degradation of mRNA (Chen et al., 2022[33]; Li et al., 2022[120]). YTHDF2 controls the activity of METTL3, which has an impact on translation and mRNA stability (Sun et al., 2023[179]). The dynamic interaction between YTHDF2 and METTL3 plays a major role in controlling post-transcriptional gene expression in cells (Wang et al., 2022[194]). Jin et al. showed smoking cigarettes causes aberrant m6A alteration, which is connected to the development of NSCLC. The m6A METTL3 and the m6A YTHDF2 facilitate this change, which results in a reduction in the stability and expression of DAPK2 mRNA. The m6A METTL3 and m6A YTHDF2 mediate this change. Additionally, the study shows that DAPK2 suppresses tumors and that its downregulation increases the capacity for migration and proliferation by triggering the NF-κB signaling pathway. The results show that smoking cigarettes alters DAPK2, which may be a therapeutic target for patients with NSCLC caused by smoking and provide new information on the mechanisms behind the development of NSCLC (Jin et al., 2021[94]). Similarly, According to Wang et al.'s analysis, cells exposed to lung cancer and cigarettes expressed less of the m6A reader protein YTHDC2. The relationship between lower YTHDC2, smoking history, and a bad prognosis is demonstrated via tissue analysis and bioinformatics. In vivo, confirmation of YTHDC2 overexpression inhibits lung cancer cell migration and proliferation. In lung cancer, YTHDC2 decrease is modulated by copy number deletion. Notably, m6A alteration mediates YTHDC2's action as a tumor suppressor via the CYLD/NF-κB pathway, indicating a crucial connection between smoking-related YTHDC2 downregulation and accelerated lung cancer development (Wang et al., 2021[192]) (Figure 3(Fig. 3)).

Histone modifications

Histone modifications, such as acetylation, methylation, and phosphorylation, play a crucial role in regulating chromatin structure and gene expression. NF-κB activation in response to smoking can lead to changes in histone acetylation and methylation patterns, which affect the transcriptional activity of various genes involved in inflammation and tumorigenesis (Adcock et al., 2006[2]; Barnes, 2011[14]; Kaur et al., 2022[100]). Smoking-induced NF-κB activation can increase histone acetylation at specific gene promoters, enhancing the expression of pro-inflammatory cytokines and other oncogenic factors (Kaur et al., 2018[100]). Histone acetyltransferases (HATs) like p300/CBP are recruited to the promoters of NF-κB target genes, leading to increased acetylation of histones H3 and H4, which promotes gene transcription. Conversely, histone deacetylases (HDACs) can be involved in repressing the transcription of tumor suppressor genes. Smoking can disrupt the balance between HATs and HDACs, leading to aberrant gene expression patterns that favor cancer progression (Cui et al., 2013[41]).

DNA methylation

DNA methylation is another epigenetic mechanism influenced by NF-κB activation in smoking-induced lung cancer. NF-κB can interact with DNA methyltransferases (DNMTs) to modulate the methylation status of specific gene promoters (Asgarova et al., 2018[7]; Barnes, 2011[14]). Hypermethylation of tumor suppressor genes and hypomethylation of oncogenes are common features observed in smoking-related lung cancer (Kaur and Batra, 2020[99]). The promoter regions of tumor suppressor genes, such as p16 and RASSF1A, can become hypermethylated in response to chronic smoking, leading to their silencing and subsequent loss of tumor-suppressive functions (Liu et al., 2023[124]). NF-κB-mediated recruitment of DNMTs to these promoters contributes to the epigenetic silencing of crucial regulatory genes, promoting cancer development (Xiong et al., 2019[200]).

Non-coding RNAs

Non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are also regulated by NF-κB and play significant roles in smoking-induced lung carcinogenesis (Barangi et al., 2023[13]). NF-κB can modulate the expression of various miRNAs that act as either oncogenes or tumor suppressors. miR-21, an oncogenic miRNA, is upregulated in response to smoking-induced NF-κB activation (Chen et al., 2021[35]). MiR-21 targets and downregulates tumor suppressor genes such as PTEN, leading to enhanced cell survival and proliferation (Elton et al., 2013[57]). Conversely, tumor-suppressive miRNAs like miR-34a can be downregulated by smoking, further contributing to lung cancer progression (Kolenda et al., 2020[104]). LncRNAs, such as MALAT1, are also involved in NF-κB-mediated epigenetic regulation. MALAT1 has been shown to interact with NF-κB and other chromatin-modifying proteins to influence gene expression patterns associated with inflammation and cancer (Goodarzi et al., 2023[69]) (Figure 4(Fig. 4)).

Therapeutic Interventions

Extensive research has focused on elucidating NF-κB's role in smoking-induced lung cancer. Activated by cigarette smoke, NF-κB emerges as a pivotal molecular player, fostering tumorigenesis and progression (Hasnis et al., 2007[75]). Cigarette smoke triggers sustained NF-κB nuclear translocation, prompting the release of inflammatory mediators and heightened mucus cell secretion (Huang et al., 2022[89]). This smoking-induced NF-κB activation intricately regulates downstream pathways linked to lung cancer (Mei et al., 2022[137]; Thapa et al., 2024[180]). Additionally, ongoing investigations explore NF-κB inhibition as a potential therapeutic avenue for smoking-associated lung cancer (Ou et al., 2022[145]). A comprehensive understanding of the NF-κB pathway's involvement in tobacco smoke-induced lung cancer holds promise for informing the development of effective therapeutic interventions (Preciado et al., 2008[152]).

Natural compounds

Linalool is a naturally occurring terpene alcohol found in many flowers and spice plants (An et al., 2021[4]). It is classified as an acyclic monoterpenoid and has multiple commercial applications, primarily based on its pleasant scent, which is described as floral with a touch of spiciness (de Groot, 2019[44]). Linalool is a colorless oil and is used in the manufacturing of soaps, fragrances, and other products (Dos Santos É et al., 2022[54]). It is also hydrogenated to give dihydro- and tetrahydrolinalool, which are more resilient fragrances (Jiang et al., 2023[93]). Linalool has various biological properties, including antimicrobial activity (Koriem and El-Qady, 2023[106]). In recent years, there has been interest in using linalool as an active packaging, for example, by injecting it into the space above the contents of food packaging or applying it to food (Levenberg et al., 2020[117]). Linalool was found to significantly reduce lung inflammation caused by chronic sclerosis in mice by Ma et al. (2015[128]). It prevented inflammatory cell infiltration and the generation of inflammatory cytokines like IL-6, TNF-α, IL-8, IL-1β, and MCP-1. Linalool also prevented lung MPO activity and pathological alterations. Furthermore, it dose-dependently inhibited the activation of NF-κB produced by chronic sclerosis, thereby reducing chronic sclerosis-induced lung inflammation (Ma et al., 2015[128]; Thapa et al., 2023[182]).

Bromelain is an enzyme extract derived from the stems of pineapples, although it exists in all parts of the fresh pineapple (Arshad et al., 2014[6]). It is a complex combination of multiple endopeptidases of thiol and other compounds (Chobotova et al., 2010[38]). Bromelain has a history of folk medicine use and is currently used in various industries, such as cosmetics, as a topical medication, and as a meat tenderizer (Hikisz and Bernasinska-Slomczewska, 2021[79]; Thapa et al., 2023[183]). It has been studied for its various therapeutic applications, including its role as an antiedematous, fibrinolytic, anticancer, anti-inflammatory, antibiotic, anticoagulant, and antithrombotic agent (Hirche et al., 2020[81]; Kumar et al., 2023[109]). Bromelain has been shown to have anticancer effects by preventing nuclear factor κB (NF-κB) translocation and inducing G2/M arrest, which can disrupt normal apoptotic functions and help cancer cell transformation (Maurer, 2001[135]; Owoyele et al., 2020[146]). The study of Majumder et al. explored the impact of bromelain and ethanolic olive leaf extract on lung carcinogenesis. They found that the combination increases Nrf2 activity, decreases NF-κB translocation, and regulates inflammatory indicators, making it a potential method to reduce lung cancer caused by smoking (Majumder et al., 2021[131]).

Diallyl trisulfide (DATS) is an organosulfur compound found in garlic, known for its various biological activities, particularly in the context of cancer prevention and treatment (Han et al., 2017[74]). It has been reported to selectively kill cancerous cells in the prostate and breast while leaving healthy cells unharmed, attributed to increased reactive oxygen species (ROS) within cancer cells (Hsieh et al., 2020[88]; Kanga et al., 2023[98]). DATS has been investigated as an anticancer and chemopreventive agent, with in vitro studies showing its potency in reducing cell viability and its lower toxicity to non-transformed cells (Kim et al., 2023[102]; Leung et al., 2020[116]). Additionally, DATS exhibits a range of activities, including anticancer chemotherapeutic (Lin et al., 2024[121]), immunostimulatory (Puccinelli and Stan, 2017[154]), antioxidative (Rauf et al., 2022[162]), hepatoprotective, anti-fibrotic, anti-estrogenic (Wu et al., 2011[199]), anti-metastatic, anti-inflammatory, and anti-angiogenic properties (Thapa et al., 2023[186]; Zeng et al., 2008[206]). It has also been shown to modulate disease states such as cancer, infection, and metabolic syndrome. Qu et al. found that garlic oil's DATS can reduce lung carcinogenesis induced by tobacco-specific nitrosamine NNK. When injected into an A/J mouse model, DATS significantly reduced lung tumor incidence. DATS enhanced F. rodentium bacteria in the gut microbiome, inhibiting tumor growth. It also inhibited inflammatory factors and negatively regulated NF-κB signaling through the PPARγ pathway, suggesting DATS as a potential new chemopreventive treatment for lung cancer caused by tobacco use (Qu et al., 2024[157]).

Pharmaceutical drugs

Celecoxib has been evaluated as a potential cancer chemopreventive and therapeutic drug in clinical trials for various types of cancer (Bąk and Krupa, 2023[10]; Thapa et al., 2023[184]). It has been shown to have anticancer properties by preventing nuclear factor κB (NF-κB) translocation and inducing G2/M arrest, which can disrupt normal apoptotic functions and help cancer cell transformation (Fidahic et al., 2017[62]). Celecoxib is extensively metabolized through cytochrome P450 2C9 (CYP2C9) and may have interactions with other medications (Krasselt and Baerwald, 2019[107]; Papageorgiou et al., 2016[149]). Shishodia et al. studied NF-κB activation in lung cancer cells exposed to CSC. They found that celecoxib reduced persistent NF-κB activation for up to 24 hours, inhibiting the activation, phosphorylation, degradation, and nuclear translocation of I-κB elicited by CSC. Additionally, it inhibited the expression of genes reliant on NF-κB, reducing inflammation, proliferation, and angiogenesis (Shishodia and Aggarwal, 2004[170]).

Angiotensin-(1-7) (Ang-(1-7)) is a vasoactive peptide of the renin-angiotensin system (RAS), which is generated mainly by angiotensin-converting enzyme 2 (ACE2) and exerts its actions via the Ang-(1-7)/ACE2/Mas axis (de Paula Gonzaga et al., 2020[45]). It is considered to be a main mechanism that counterbalances the vasoconstrictive actions of the classical RAS. Ang-(1-7) has been reported to release nitric oxide, induce diuresis, and have a vasodilatory effect, favoring a lowering of blood pressure (de Souza-Neto et al., 2018[47]; Lelis et al., 2019[114]). It is a heptapeptide found in the heart and kidneys, with concentrations six times higher in the kidney than in plasma, highlighting its role in renal homeostasis (Luna et al., 2023[127]). Ang-(1-7) has broad effects in the cardiovascular system, including vasodilatation, myocardial protection, antiarrhythmic, antihypertensive, and positive inotropic effects, as well as inhibition of pathological cardiac remodelling (Medina and Arnold, 2019[136]; Pan et al., 2018[147]). It also has favourable effects on metabolism by lessening insulin resistance. Ang-(1-7) is considered to be an endogenous ligand for the G protein-coupled receptor Mas (Rahimi et al., 2022[158]). Zhang et al. studied Angiotensin-(1-7) in relation to cigarette smoke-induced COPD in C57BL/6J mice. Although Ang-(1-7) could not stop emphysema and lung function deterioration caused by cigarette smoke, it successfully reduced lung fibrosis and inflammation. The study suggests Ang-(1-7) has potential in treating emphysema and lung function impairment, possibly through the NF-κB pathway (Zhang et al., 2018[208]).

NSAIDs lower fever, lessen inflammation, and relieve pain. They function by preventing prostaglandins, which are molecules involved in the inflammatory response, from being produced (Bindu et al., 2020[24]; Ding, 2022[51]). NSAIDs, which are often used to treat ailments including arthritis, include aspirin, ibuprofen, and naproxen (García-Rayado et al., 2018[65]). NSAIDs are useful, but they should be used carefully since they can cause gastrointestinal discomfort and should be taken for extended periods or at high doses (Gurpinar et al., 2014[73]; Panchal and Prince Sabina, 2023[148]). Rioux et al. found that NSAIDs can prevent lung tumor growth when NNK, a smoking-related carcinogen, is present. They found that COX-1 and -enzymes mediate the conversion of NNK into carcinogenic substances in human macrophages. NSAIDs, like acetylsalicylic acid and NS-398, decreased COX-dependent NNK activation by 66 % and 37 %, respectively. This suggested that inhibiting NF-kappaB activation may be a unique way to prevent lung cancer (Rioux and Castonguay, 2000[163]; Thapa et al., 2023[185]).

Challenges and Future Directions

Lung cancer growth is specifically impacted by the precise processes of NF-κB activation in response to stress caused by smoking, which are yet not fully understood. While it is known that cigarette smoke can activate NF-κB, the detailed interplay between NF-κB and other signaling pathways implicated in lung cancer development remains a subject of ongoing research. Not all smokers develop lung cancer, and the disease can also arise in lifetime non-smokers, indicating a complex interplay of genetic and environmental factors. Understanding the variability in disease susceptibility and the specific role of NF-κB in this context is a significant challenge. The variation in disease susceptibility has stimulated interest in molecular epidemiologic investigations to better understand the molecular mechanisms underlying the link between smoking, NF-κB, and lung cancer development.

Further research must focus on elucidating the exact mechanisms by which NF-κB is activated in response to smoking-related stress, as well as its distinct roles in the development and progression of smoking-related lung cancer. Personalized therapy solutions will require the completion of extensive molecular epidemiology research to determine genetic and environmental variables that modify NF-κB activity and its connection with smoking-induced lung cancer. It has potential to develop tailored therapy techniques that modify NF-κB activity in lung cancer caused by smoking. This involves investigating drugs that can precisely target the NF-κB signaling system, such as NF-κB inhibitors, for the treatment and prevention of lung cancer caused by smoking.

Conclusion

In overview, study of the function of NF-κB in smoking-induced lung cancer has shown a complicated web of molecular processes that play a role in the onset and spread of this deadly illness. This review has compiled important data and insights from a thorough investigation of the literature, illuminating the complex relationship between NF-κB and the toxic breath of smoking-induced lung cancer. NF-κB, a transcription factor with diverse cellular functions, emerges as a central orchestrator in the response to cigarette smoke exposure. Its activation is intricately linked to chronic inflammation, immune modulation, and cell survival - all pivotal processes in the pathogenesis of lung cancer. A thorough examination of NF-κB's unique contributions is crucial because of the milieu that is favorable to cancer created by the interaction between this protein and the several carcinogens found in cigarette smoke. The pro-inflammatory and pro-survival activities of NF-κB in the context of smoking-induced lung cancer underline its potential as a therapeutic target. Via clarifying the molecular pathways via which NF-κB affects the development of cancer, scientists are able to identify important targets for intervention and prevention.

Declaration

Ethics approval and consent to participate

Not applicable to a review article.

Consent for publication

All authors gave their consent for publication.

Availability of data and materials

Not applicable as no novel data were generated for this review article.

Competing interests

No authors have any conflict of interest or competing interests to declare.

Funding

No funding was received to perform this study.

Author contributions

RT, EM, and AG researched the data. AAB, WHA, IK, SIA, and HA wrote the first draft of the manuscript. BGO, RM, HD, SKS, and GG edited the manuscript. KD was responsible for conceptualization and supervision. All authors reviewed and approved the final version of the manuscript. Kamal Dua is the guarantor of this work.

Acknowledgments

None.

Table 1 This table provides a concise summary of studies related to smoking-induced lung cancer, detailing various models, mechanisms, biological significance, key findings, and factors inducing changes in each study.

Figure 1 Graphical abstract

Figure 2 This image shows NF-κB pathways, pivotal in immune responses. Toll-like receptors (TLR), T-cell receptors (TCR), and tumor necrosis factor receptors (TNFR) activate NF-κB, influencing immune and inflammatory processes.

Figure 3 This image reveals that lung cancer-exposed cells express less YTHDC2, linked to smoking history and poor prognosis. YTHDC2 overexpression inhibits cancer in vivo, influenced by copy number deletion, and m6A alteration mediates its tumor-suppressive role via the CYLD/NF-κB pathway. A vital connection is established between smoking-induced YTHDC2 downregulation and accelerated lung cancer development.

Figure 4 The figure illustrates epigenetic mechanisms in cancer: Histone modifications lead to changes in gene expression and chromatin structure; DNA methylation loss results in aberrant transcription of target genes; Non-coding RNA regulation alters transcription and translation of oncogenic gene targets.
==== Refs
1 Abubakar M Puppala ER Dutta BJ Maharana KC Thapa R Roshan S Gupta G Oliver BG Dua K Ali MK Dave P Epigenetics of rhinovirus Targeting epigenetics in inflammatory lung diseases 2023 Singapore Springer 185 197 10.1007/978-981-99-4780-5_11 Available from: 10.1007/978-981-99-4780-5_11
2 Adcock IM Ford P Ito K Barnes PJ Epigenetics and airways disease Respir Res 2006 7 1 21 10.1186/1465-9921-7-21 Available from: 10.1186/1465-9921-7-21 16460559
3 Aidinidou L Chatzikyriakidou A Giannopoulos A Karpa V Tzimou I Aidinidou E Association of NFKB1, NKX2-5, GATA4 and RANKL gene polymorphisms with sporadic congenital heart disease in Greek patients Balkan J Med Genet 2021 24 1 15 20 10.2478/bjmg-2021-0014 Available from: 10.2478/bjmg-2021-0014
4 An Q Ren JN Li X Fan G Qu SS Song Y Recent updates on bioactive properties of linalool Food Funct 2021 12 10370 10389 10.1039/d1fo02120f Available from: 10.1039/d1fo02120f 34611674
5 Armstrong B Hutchinson E Unwin J Fletcher T Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis Environ Health Perspect 2004 112 970 978 10.1289/ehp.6895 Available from: 10.1289/ehp.6895 15198916
6 Arshad ZI Amid A Yusof F Jaswir I Ahmad K Loke SP Bromelain: an overview of industrial application and purification strategies Appl Microbiol Biotechnol 2014 98 7283 7297 10.1007/s00253-014-5889-y Available from: 10.1007/s00253-014-5889-y 24965557
7 Asgarova A Asgarov K Godet Y Peixoto P Nadaradjane A Boyer-Guittaut M PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma Oncoimmunology 2018 7 5 e1423170 10.1080/2162402x.2017.1423170 Available from: 10.1080/2162402x.2017.1423170 29721376
8 Aswini YB The genomics of oral cancer and wound healing J Indian Soc Pedod Prev Dent 2009 27 1 2 5 10.4103/0970-4388.50808 Available from: 10.4103/0970-4388.50808 19414966
9 Baglole CJ Maggirwar SB Gasiewicz TA Thatcher TH Phipps RP Sime PJ The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB J Biol Chem 2008 283 28944 28957 10.1074/jbc.M800685200 Available from: 10.1074/jbc.M800685200 18697742
10 Bąk U Krupa A Challenges and opportunities for celecoxib repurposing Pharm Res 2023 40 2329 2345 10.1007/s11095-023-03571-4 Available from: 10.1007/s11095-023-03571-4 37552383
11 Balaga VKR Pradhan A Thapa R Patel N Mishra R Singla N Morin: A comprehensive review on its versatile biological activity and associated therapeutic potential in treating cancers Pharmacol Res 2023 7 100264 10.1016/j.prmcm.2023.100264 Available from: 10.1016/j.prmcm.2023.100264
12 Bao X Luo X Bai X Lv Y Weng X Zhang S Cigarette tar mediates macrophage ferroptosis in atherosclerosis through the hepcidin/FPN/SLC7A11 signaling pathway Free Radic Biol Med 2023 201 76 88 10.1016/j.freeradbiomed.2023.03.006 Available from: 10.1016/j.freeradbiomed.2023.03.006 36933812
13 Barangi S Hayes AW Karimi G The role of lncRNAs/miRNAs/Sirt1 axis in myocardial and cerebral injury Cell Cycle 2023 22 1062 1073 10.1080/15384101.2023.2172265 Available from: 10.1080/15384101.2023.2172265 36703306
14 Barnes PJ Pathophysiology of allergic inflammation Immunol Rev 2011 242 1 31 50 10.1111/j.1600-065X.2011.01020.x Available from: 10.1111/j.1600-065X.2011.01020.x 21682737
15 Benowitz NL Donny EC Hatsukami DK Reduced nicotine content cigarettes, e-cigarettes and the cigarette end game Addiction 2017 112 1 6 7 10.1111/add.13534 Available from: 10.1111/add.13534 27555354
16 Bernard MP Bancos S Sime PJ Phipps RP Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise Curr Pharm Des 2008 14 2051 2060 10.2174/138161208785294654 Available from: 10.2174/138161208785294654 18691115
17 Bhalla S Mehan S Khan A Rehman MU Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions Neurosci Biobehav Rev 2022 142 104896 10.1016/j.neubiorev.2022.104896 Available from: 10.1016/j.neubiorev.2022.104896 36191807
18 Bhat AA Afzal O Afzal M Gupta G Thapa R Ali H MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting Pathol Res Pract 2024 253 154991 10.1016/j.prp.2023.154991 Available from: 10.1016/j.prp.2023.154991 38070223
19 Bhat AA Afzal O Agrawal N Thapa R Almalki WH Kazmi I A comprehensive review on the emerging role of long non-coding RNAs in the regulation of NF-κB signaling in inflammatory lung diseases Int J Biol Macromol 2023 253 Pt 4 126951 10.1016/j.ijbiomac.2023.126951 Available from: 10.1016/j.ijbiomac.2023.126951 37734525
20 Bhat AA Goyal A Thapa R Kazmi I Alzarea SI Singh M Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer Cytokine 2023 171 156376 10.1016/j.cyto.2023.156376 Available from: 10.1016/j.cyto.2023.156376 37748333
21 Bhat AA Gupta G Afzal M Thapa R Ali H Alqahtani SM Polyphenol-loaded nano-carriers for breast cancer therapy: a comprehensive review BioNanoScience 2024 epub ahead of print 10.1007/s12668-023-01288-7 Available from: 10.1007/s12668-023-01288-7
22 Bhat AA Gupta G Goyal A Thapa R Almalki WH Kazmi I Unwinding circular RNA’s role in inflammatory pulmonary diseases Naunyn Schmiedebergs Arch Pharmacol 2024 397 2567 2588 10.1007/s00210-023-02809-7 Available from: 10.1007/s00210-023-02809-7 37917370
23 Bhat AA Thapa R Goyal A Subramaniyan V Kumar D Gupta S Curcumin-based nanoformulations as an emerging therapeutic strategy for inflammatory lung diseases Future Med Chem 2023 15 583 586 10.4155/fmc-2023-0048 Available from: 10.4155/fmc-2023-0048 37140132
24 Bindu S Mazumder S Bandyopadhyay U Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective Biochem Pharmacol 2020 180 114147 10.1016/j.bcp.2020.114147 Available from: 10.1016/j.bcp.2020.114147 32653589
25 Bitzer ZT Mocniak LE Trushin N Smith M Richie JP Influence of tobacco variety and curing on free radical production in cigarette smoke Nicotine Tob Res 2023 25 1400 1405 10.1093/ntr/ntad049 Available from: 10.1093/ntr/ntad049 36967618
26 Blum TG Morgan RL Durieux V Chorostowska-Wynimko J Baldwin DR Boyd J European Respiratory Society guideline on various aspects of quality in lung cancer care Eur Respir J 2023 61 2 2103201 10.1183/13993003.03201-2021 Available from: 10.1183/13993003.03201-2021 36396145
27 Breitbarth AK Morgan J Jones AL E-cigarettes - An unintended illicit drug delivery system Drug Alcohol Depend 2018 192 98 111 10.1016/j.drugalcdep.2018.07.031 Available from: 10.1016/j.drugalcdep.2018.07.031 30245461
28 Brown BG Borschke AJ Doolittle DJ An analysis of the role of tobacco-specific nitrosamines in the carcinogenicity of tobacco smoke Nonlinearity Biol Toxicol Med 2003 1 179 198 10.1080/15401420391434324 Available from: 10.1080/15401420391434324 19330121
29 Cai B Liu M Li J Xu D Li J Cigarette smoke extract amplifies NADPH oxidase-dependent ROS production to inactivate PTEN by oxidation in BEAS-2B cells Food Chem Toxicol 2021 150 112050 10.1016/j.fct.2021.112050 Available from: 10.1016/j.fct.2021.112050 33577944
30 Cartwright T Perkins ND C LW NFKB1: a suppressor of inflammation, ageing and cancer Febs J 2016 283 1812 1822 10.1111/febs.13627 Available from: 10.1111/febs.13627 26663363
31 Chang JT Anic GM Rostron BL Tanwar M Chang CM Cigarette smoking reduction and health risks: a systematic review and meta-analysis Nicotine Tob Res 2021 23 635 642 10.1093/ntr/ntaa156 Available from: 10.1093/ntr/ntaa156 32803250
32 Chen H Pan Y Zhou Q Liang C Wong CC Zhou Y METTL3 inhibits antitumor immunity by targeting m(6)A-BHLHE41-CXCL1/CXCR2 axis to promote colorectal cancer Gastroenterology 2022 163 891 907 10.1053/j.gastro.2022.06.024 Available from: 10.1053/j.gastro.2022.06.024 35700773
33 Chen L Zhang C Ma W Huang J Zhao Y Liu H METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability Nucleic Acids Res 2022 50 11619 11634 10.1093/nar/gkac1027 Available from: 10.1093/nar/gkac1027 36399511
34 Chen QJ Lai HM Zhao L Ma YT Li XM Zhai H Association between the NFKB1-94ins/del ATTG polymorphism (rs28362491) and coronary artery disease: a systematic review and meta-analysis Genet Test Mol Biomarkers 2016 20 105 111 10.1089/gtmb.2015.0242 Available from: 10.1089/gtmb.2015.0242 26799199
35 Chen Y Li Z Chen X Zhang S Long non-coding RNAs: From disease code to drug role Acta Pharm Sin B 2021 11 340 354 10.1016/j.apsb.2020.10.001 Available from: 10.1016/j.apsb.2020.10.001 33643816
36 Chen Z Liu N Tang H Gao X Zhang Y Kan H Health effects of exposure to sulfur dioxide, nitrogen dioxide, ozone, and carbon monoxide between 1980 and 2019: A systematic review and meta-analysis Indoor Air 2022 32 11 e13170 10.1111/ina.13170 Available from: 10.1111/ina.13170 36437665
37 Chiang HC Hughes M Chang WL The role of microbiota in esophageal squamous cell carcinoma: A review of the literature Thorac Cancer 2023 14 2821 2829 10.1111/1759-7714.15096 Available from: 10.1111/1759-7714.15096 37675608
38 Chobotova K Vernallis AB Majid FA Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives Cancer Lett 2010 290 148 156 10.1016/j.canlet.2009.08.001 Available from: 10.1016/j.canlet.2009.08.001 19700238
39 Conlon TM John-Schuster G Heide D Pfister D Lehmann M Hu Y Inhibition of LTβR signalling activates WNT-induced regeneration in lung Nature 2020 588 7836 151 156 10.1038/s41586-020-2882-8 Available from: 10.1038/s41586-020-2882-8 33149305
40 Crosbie E Hartman J Tran B Bialous S Promoting healthier options? Inside the branding of light cigarettes and targeting youth in Brazil Glob Public Health 2022 17 1913 1923 10.1080/17441692.2021.2003840 Available from: 10.1080/17441692.2021.2003840 34852728
41 Cui ZL Gu W Ding T Peng XH Chen X Luan CY Histone modifications of Notch1 promoter affect lung CD4+ T cell differentiation in asthmatic rats Int J Immunopathol Pharmacol 2013 26 371 381 10.1177/039463201302600210 Available from: 10.1177/039463201302600210 23755752
42 Daigneault M Preston JA Marriott HM Whyte MK Dockrell DH The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages PLoS One 2010 5 1 e8668 10.1371/journal.pone.0008668 Available from: 10.1371/journal.pone.0008668 20084270
43 Dang X He B Ning Q Liu Y Guo J Niu G Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-κB pathways Respir Res 2020 21 1 95 10.1186/s12931-020-01358-4 Available from: 10.1186/s12931-020-01358-4 32321531
44 de Groot A Linalool hydroperoxides Dermatitis 2019 30 243 246 10.1097/der.0000000000000471 Available from: 10.1097/der.0000000000000471 31313746
45 de Paula Gonzaga A Palmeira VA Ribeiro TFS Costa LB de Sá Rodrigues KE Simões ESAC ACE2/Angiotensin-(1-7)/Mas receptor axis in human cancer: potential role for pediatric tumors Curr Drug Targets 2020 21 892 901 10.2174/1389450121666200210124217 Available from: 10.2174/1389450121666200210124217 32039680
46 de Sousa VML Carvalho L Heterogeneity in lung cancer Pathobiology 2018 85 1-2 96 107 10.1159/000487440 Available from: 10.1159/000487440 29635240
47 de Souza-Neto FP Carvalho Santuchi M de Morais ESM Campagnole-Santos MJ da Silva RF Angiotensin-(1-7) and alamandine on experimental models of hypertension and atherosclerosis Curr Hypertens Rep 2018 20 2 17 10.1007/s11906-018-0798-6 Available from: 10.1007/s11906-018-0798-6 29541937
48 Dela Cruz CS Tanoue LT Matthay RA Lung cancer: epidemiology, etiology, and prevention Clin Chest Med 2011 32 605 644 10.1016/j.ccm.2011.09.001 Available from: 10.1016/j.ccm.2011.09.001 22054876
49 Deng M Tong R Bian Y Hou G Astaxanthin attenuates cigarette smoking-induced oxidative stress and inflammation in a sirtuin 1-dependent manner Biomed Pharmacother 2023 159 114230 10.1016/j.biopha.2023.114230 Available from: 10.1016/j.biopha.2023.114230 36696799
50 DiDonato JA Mercurio F Karin M NF-κB and the link between inflammation and cancer Immunol Rev 2012 246 1 379 400 10.1111/j.1600-065X.2012.01099.x Available from: 10.1111/j.1600-065X.2012.01099.x 22435567
51 Ding C Do NSAIDs affect the progression of osteoarthritis? Inflammation 2002 26 139 142 10.1023/a:1015504632021 Available from: 10.1023/a:1015504632021 12083420
52 Ding YS Zhang L Jain RB Jain N Wang RY Ashley DL Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties Cancer Epidemiol Biomarkers Prev 2008 17 3366 3371 10.1158/1055-9965.Epi-08-0320 Available from: 10.1158/1055-9965.Epi-08-0320 19064552
53 Doré M Cyclooxygenase-2 expression in animal cancers Vet Pathol 2011 48 1 254 265 10.1177/0300985810379434 Available from: 10.1177/0300985810379434 20876365
54 Dos Santos É RQ Maia JGS Fontes-Júnior EA do Socorro Ferraz Maia C Linalool as a therapeutic and medicinal tool in depression treatment: a review Curr Neuropharmacol 2022 20 1073 1092 10.2174/1570159x19666210920094504 Available from: 10.2174/1570159x19666210920094504 34544345
55 Dubin S Griffin D Lung cancer in non-smokers Mo Med 2020 117 4 375 379 32848276
56 Edwards SH Hassink MD Taylor KM Watson CH Kuklenyik P Kimbrell B Tobacco-specific nitrosamines in the tobacco and mainstream smoke of commercial little cigars Chem Res Toxicol 2021 34 1034 1045 10.1021/acs.chemrestox.0c00367 Available from: 10.1021/acs.chemrestox.0c00367 33667338
57 Elton TS Selemon H Elton SM Parinandi NL Regulation of the MIR155 host gene in physiological and pathological processes Gene 2013 532 1 1 12 10.1016/j.gene.2012.12.009 Available from: 10.1016/j.gene.2012.12.009 23246696
58 Eluard B Thieblemont C Baud V NF-κB in the new era of cancer therapy Trends Cancer 2020 6 677 687 10.1016/j.trecan.2020.04.003 Available from: 10.1016/j.trecan.2020.04.003 32409139
59 Escós A Martín-Gómez J González-Romero D Díaz-Mora E Francisco-Velilla R Santiago C TPL2 kinase expression is regulated by the p38γ/p38δ-dependent association of aconitase-1 with TPL2 mRNA Proc Natl Acad Sci U S A 2022 119 35 e2204752119 10.1073/pnas.2204752119 Available from: 10.1073/pnas.2204752119 35994673
60 Fan Y Mao R Yang J NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer Protein Cell 2013 4 176 185 10.1007/s13238-013-2084-3 Available from: 10.1007/s13238-013-2084-3 23483479
61 Fang X Zhang S Wang Z Zhou J Qi C Song J Cigarette smoke extract combined with LPS down-regulates the expression of MRP2 in chronic pulmonary inflammation may be related to FXR Mol Immunol 2021 137 174 186 10.1016/j.molimm.2021.06.019 Available from: 10.1016/j.molimm.2021.06.019 34273652
62 Fidahic M Jelicic Kadic A Radic M Puljak L Celecoxib for rheumatoid arthritis Cochrane Database Syst Rev 2017 6 6 Cd012095 10.1002/14651858.CD012095.pub2 Available from: 10.1002/14651858.CD012095.pub2 28597983
63 Frejborg E Salo T Salem A Role of cyclooxygenase-2 in head and neck tumorigenesis Int J Mol Sci 2020 21 23 9246 10.3390/ijms21239246 Available from: 10.3390/ijms21239246 33287464
64 Gankhuyag N Lee KH Cho JY The role of nitrosamine (NNK) in breast cancer carcinogenesis J Mammary Gland Biol Neoplasia 2017 22 159 170 10.1007/s10911-017-9381-z Available from: 10.1007/s10911-017-9381-z 28664511
65 García-Rayado G Navarro M Lanas A NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs Expert Rev Clin Pharmacol 2018 11 1031 1043 10.1080/17512433.2018.1516143 Available from: 10.1080/17512433.2018.1516143 30139288
66 Geffken SJ Moon S Smith CO Tang S Lee HH Lewis K Insulin and IGF-1 elicit robust transcriptional regulation to modulate autophagy in astrocytes Mol Metab 2022 66 101647 10.1016/j.molmet.2022.101647 Available from: 10.1016/j.molmet.2022.101647 36503893
67 Gellner CA Reynaga DD Leslie FM Cigarette smoke extract: a preclinical model of tobacco dependence Curr Protoc Neurosci 2016 77 9.54 10.1002/cpns.14 Available from: 10.1002/cpns.14
68 Gonçalves RB Coletta RD Silvério KG Benevides L Casati MZ da Silva JS Impact of smoking on inflammation: overview of molecular mechanisms Inflamm Res 2011 60 409 424 10.1007/s00011-011-0308-7 Available from: 10.1007/s00011-011-0308-7 21298317
69 Goodarzi V Nouri S Nassaj ZS Bighash M Abbasian S Hagh RA Long non coding RNAs reveal important pathways in childhood asthma: a future perspective J Mol Histol 2023 54 257 269 10.1007/s10735-023-10131-y Available from: 10.1007/s10735-023-10131-y 37537509
70 Guo H Wei J Li X Ho HC Song Y Wu J Do socioeconomic factors modify the effects of PM1 and SO2 on lung cancer incidence in China? Sci Total Environ 2021 756 143998 10.1016/j.scitotenv.2020.143998 Available from: 10.1016/j.scitotenv.2020.143998 33310217
71 Guo Y Liu Z Wang M NFKB1-mediated downregulation of microRNA-106a promotes oxidative stress injury and insulin resistance in mice with gestational hypertension Cytotechnology 2021 73 1 115 126 10.1007/s10616-020-00448-x Available from: 10.1007/s10616-020-00448-x 33505119
72 Gupta G Hussain MS Thapa R Dahiya R Mahapatra DK Bhat AA Hope on the horizon: Wharton's jelly mesenchymal stem cells in the fight against COVID-19 Regen Med 2023 18 675 678 10.2217/rme-2023-0077 Available from: 10.2217/rme-2023-0077 37554111
73 Gurpinar E Grizzle WE Piazza GA NSAIDs inhibit tumorigenesis, but how? Clin Cancer Res 2014 20 1104 1113 10.1158/1078-0432.Ccr-13-1573 Available from: 10.1158/1078-0432.Ccr-13-1573 24311630
74 Han W Wang S Jiang L Wang H Li M Wang X Diallyl trisulfide (DATS) suppresses benzene-induced cytopenia by modulating haematopoietic cell apoptosis Environ Pollut 2017 231 Pt 1 301 310 10.1016/j.envpol.2017.07.069 Available from: 10.1016/j.envpol.2017.07.069 28810199
75 Hasnis E Bar-Shai M Burbea Z Reznick AZ Mechanisms underlying cigarette smoke-induced NF-kappaB activation in human lymphocytes: the role of reactive nitrogen species J Physiol Pharmacol 2007 58 Suppl 5 275 287
76 He X Li T Luo L Zeng H Chen Y Cai S PRMT6 mediates inflammation via activation of the NF-κB/p65 pathway on a cigarette smoke extract-induced murine emphysema model Tob Induc Dis 2020 18 8 10.18332/tid/116413 Available from: 10.18332/tid/116413 32047419
77 Hellstrom A Ley D Hallberg B Lofqvist C Hansen-Pupp I Ramenghi LA IGF-1 as a drug for preterm infants: a step-wise clinical development Curr Pharm Des 2017 23 5964 5970 10.2174/1381612823666171002114545 Available from: 10.2174/1381612823666171002114545 28969546
78 Higashi Y Gautam S Delafontaine P Sukhanov S IGF-1 and cardiovascular disease Growth Horm IGF Res 2019 45 6 16 10.1016/j.ghir.2019.01.002 Available from: 10.1016/j.ghir.2019.01.002 30735831
79 Hikisz P Bernasinska-Slomczewska J Beneficial properties of bromelain Nutrients 2021 13 12 4313 10.3390/nu13124313 Available from: 10.3390/nu13124313 34959865
80 Hirano T IL-6 in inflammation, autoimmunity and cancer Int Immunol 2021 33 127 148 10.1093/intimm/dxaa078 Available from: 10.1093/intimm/dxaa078 33337480
81 Hirche C Kreken Almeland S Dheansa B Fuchs P Governa M Hoeksema H Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update Burns 2020 46 782 796 10.1016/j.burns.2020.03.002 Available from: 10.1016/j.burns.2020.03.002 32241591
82 Hirsch FR Scagliotti GV Mulshine JL Kwon R Curran WJ Jr Wu YL Lung cancer: current therapies and new targeted treatments Lancet 2017 389 10066 299 311 10.1016/s0140-6736(16)30958-8 Available from: 10.1016/s0140-6736(16)30958-8 27574741
83 Hodge AL Baxter AA Poon IKH Gift bags from the sentinel cells of the immune system: The diverse role of dendritic cell-derived extracellular vesicles J Leukoc Biol 2022 111 903 920 10.1002/jlb.3ru1220-801r Available from: 10.1002/jlb.3ru1220-801r 34699107
84 Hoesel B Schmid JA The complexity of NF-κB signaling in inflammation and cancer Mol Cancer 2013 12 86 10.1186/1476-4598-12-86 Available from: 10.1186/1476-4598-12-86 23915189
85 Holme JA Vondráček J Machala M Lagadic-Gossmann D Vogel CFA Le Ferrec E Lung cancer associated with combustion particles and fine particulate matter (PM(2.5)) - The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR) Biochem Pharmacol 2023 216 115801 10.1016/j.bcp.2023.115801 Available from: 10.1016/j.bcp.2023.115801 37696458
86 Hou W Hu S Li C Ma H Wang Q Meng G Cigarette smoke induced lung barrier dysfunction, emt, and tissue remodeling: a possible link between COPD and lung cancer BioMed Res Int 2019 2019 2025636 10.1155/2019/2025636 Available from: 10.1155/2019/2025636 31341890
87 Hoy H Lynch T Beck M Surgical treatment of lung cancer Crit Care Nurs Clin North Am 2019 31 303 313 10.1016/j.cnc.2019.05.002 Available from: 10.1016/j.cnc.2019.05.002 31351552
88 Hsieh DJ Ng SC Zeng RY Padma VV Huang CY Kuo WW Diallyl Trisulfide (DATS) suppresses AGE-induced cardiomyocyte apoptosis by targeting ROS-mediated PKCδ activation Int J Mol Sci 2020 21 7 2608 10.3390/ijms21072608 Available from: 10.3390/ijms21072608 32283691
89 Huang D Su L He C Chen L Huang D Peng J Pristimerin alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease via inhibiting NF-κB pathway Biochem Cell Biol 2022 100 223 235 10.1139/bcb-2021-0251 Available from: 10.1139/bcb-2021-0251 35833632
90 Huang S Yang J Shen N Xu Q Zhao Q Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective Semin Cancer Biol 2023 89 30 37 10.1016/j.semcancer.2023.01.006 Available from: 10.1016/j.semcancer.2023.01.006 36682439
91 Huang X Guan W Xiang B Wang W Xie Y Zheng J MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model Respir Res 2022 23 1 11 10.1186/s12931-021-01920-8 Available from: 10.1186/s12931-021-01920-8 35042537
92 Hussain MS Gupta G Goyal A Thapa R Almalki WH Kazmi I From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disorders J Biochem Mol Toxicol 2023 37 11 e23482 10.1002/jbt.23482 Available from: 10.1002/jbt.23482 37530602
93 Jiang Y Pan X Li Y Yang Y Jia Y Lei B Linalool induces resistance against tobacco mosaic virus in tobacco plants Plant Dis 2023 107 2144 2152 10.1094/pdis-09-22-2246-re Available from: 10.1094/pdis-09-22-2246-re 36917091
94 Jin M Li G Liu W Wu X Zhu J Zhao D Cigarette smoking induces aberrant N(6)-methyladenosine of DAPK2 to promote non-small cell lung cancer progression by activating NF-κB pathway Cancer Lett 2021 518 214 229 10.1016/j.canlet.2021.07.022 Available from: 10.1016/j.canlet.2021.07.022 34298122
95 Jin SY Luo JY Li XM Liu F Ma YT Gao XM NFKB1 gene rs28362491 polymorphism is associated with the susceptibility of acute coronary syndrome Biosci Rep 2019 39 4 BSR20182292 10.1042/bsr20182292 Available from: 10.1042/bsr20182292 30910844
96 Johannessen CM Boehm JS Kim SY Thomas SR Wardwell L Johnson LA COT drives resistance to RAF inhibition through MAP kinase pathway reactivation Nature 2010 468 7326 968 972 10.1038/nature09627 Available from: 10.1038/nature09627 21107320
97 Jomova K Raptova R Alomar SY Alwasel SH Nepovimova E Kuca K Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging Arch Toxicol 2023 97 2499 2574 10.1007/s00204-023-03562-9 Available from: 10.1007/s00204-023-03562-9 37597078
98 Kanga KJW Kanga LHB Mendonca P Soliman KFA Ferguson DT Reed SL Attenuative effect of diallyl trisulfide on caspase activity in TNF-α-induced triple negative breast cancer cells Anticancer Res 2023 43 2393 2405 10.21873/anticanres.16407 Available from: 10.21873/anticanres.16407 37247921
99 Kaur G Batra S Regulation of DNA methylation signatures on NF-κB and STAT3 pathway genes and TET activity in cigarette smoke extract-challenged cells/COPD exacerbation model in vitro Cell Biol Toxicol 2020 36 459 480 10.1007/s10565-020-09522-8 Available from: 10.1007/s10565-020-09522-8 32342329
100 Kaur J Gulati M Corrie L Awasthi A Jha NK Chellappan DK Role of nucleic acid-based polymeric micelles in treating lung diseases Nanomedicine 2022 17 1951 1960 10.2217/nnm-2022-0260 Available from: 10.2217/nnm-2022-0260 36606499
101 Khan H Ullah H Castilho P Gomila AS D'Onofrio G Filosa R Targeting NF-κB signaling pathway in cancer by dietary polyphenols Crit Rev Food Sci Nutr 2020 60 2790 2800 10.1080/10408398.2019.1661827 Available from: 10.1080/10408398.2019.1661827 31512490
102 Kim MY Bang E Hwangbo H Ji SY Kim DH Lee H Diallyl trisulfide inhibits monosodium urate-induced NLRP3 inflammasome activation via NOX3/4-dependent mitochondrial oxidative stress in RAW 264.7 and bone marrow-derived macrophages Phytomedicine 2023 112 154705 10.1016/j.phymed.2023.154705 Available from: 10.1016/j.phymed.2023.154705 36796188
103 Kim SL Choi HS Lee DS BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells Cell Commun Signal 2023 21 1 315 10.1186/s12964-023-01319-6 Available from: 10.1186/s12964-023-01319-6 37924094
104 Kolenda T Guglas K Kopczyńska M Sobocińska J Teresiak A Bliźniak R Good or not good: Role of miR-18a in cancer biology Rep Pract Oncol Radiother 2020 25 808 819 10.1016/j.rpor.2020.07.006 Available from: 10.1016/j.rpor.2020.07.006 32884453
105 Kordiak J Bielec F Jabłoński S Pastuszak-Lewandoska D Role of beta-carotene in lung cancer primary chemoprevention: a systematic review with meta-analysis and meta-regression Nutrients 2022 14 7 1361 10.3390/nu14071361 Available from: 10.3390/nu14071361 35405977
106 Koriem KMM El-Qady SWB Linalool attenuates hypothalamus proteome disturbance facilitated by methamphetamine induced neurotoxicity in rats Neurotoxicology 2023 99 70 81 10.1016/j.neuro.2023.09.007 Available from: 10.1016/j.neuro.2023.09.007 37729970
107 Krasselt M Baerwald C Celecoxib for the treatment of musculoskeletal arthritis Expert Opin Pharmacother 2019 20 1689 1702 10.1080/14656566.2019.1645123 Available from: 10.1080/14656566.2019.1645123 31339385
108 Krizan Z Johar O Narcissistic rage revisited J Pers Soc Psychol 2015 108 784 801 10.1037/pspp0000013 Available from: 10.1037/pspp0000013 25545840
109 Kumar V Mangla B Javed S Ahsan W Kumar P Garg V Bromelain: a review of its mechanisms, pharmacological effects and potential applications Food Funct 2023 14 8101 8128 10.1039/d3fo01060k Available from: 10.1039/d3fo01060k 37650738
110 Kunnumakkara AB Shabnam B Girisa S Harsha C Banik K Devi TB Inflammation, NF-κB, and chronic diseases: how are they linked? Crit Rev Immunol 2020 40 1 1 39 10.1615/CritRevImmunol.2020033210 Available from: 10.1615/CritRevImmunol.2020033210 32421977
111 Lalle G Twardowski J Grinberg-Bleyer Y NF-κB in cancer immunity: friend or foe? Cells 2021 10 2 355 10.3390/cells10020355 Available from: 10.3390/cells10020355 33572260
112 Lawrence T Macrophages and NF-κB in cancer Curr Top Microbiol Immunol 2011 349 171 184 10.1007/82_2010_100 Available from: 10.1007/82_2010_100 21080151
113 Lee E Kazerooni EA Lung cancer screening Semin Respir Crit Care Med 2022 43 839 850 10.1055/s-0042-1757885 Available from: 10.1055/s-0042-1757885 36442474
114 Lelis DF Freitas DF Machado AS Crespo TS Santos SHS Angiotensin-(1-7), adipokines and inflammation Metabolism 2019 95 36 45 10.1016/j.metabol.2019.03.006 Available from: 10.1016/j.metabol.2019.03.006 30905634
115 Leone A Caroppo A Manni A Siciliano P Vision-based road rage detection framework in automotive safety applications Sensors (Basel) 2021 21 9 2942 10.3390/s21092942 Available from: 10.3390/s21092942 33922146
116 Leung WS Kuo WW Ju DT Wang TD Shao-Tsu Chen W Ho TJ Protective effects of diallyl trisulfide (DATS) against doxorubicin-induced inflammation and oxidative stress in the brain of rats Free Radic Biol Med 2020 160 141 148 10.1016/j.freeradbiomed.2020.07.018 Available from: 10.1016/j.freeradbiomed.2020.07.018 32745770
117 Levenberg K Edris W Levine M George DR Considering a potential role of linalool as a mood stabilizer for bipolar disorder Curr Pharm Des 2020 26 5128 5133 10.2174/1381612826666200724160742 Available from: 10.2174/1381612826666200724160742 32713332
118 Li L Zhang ZT Genetic Association between NFKBIA and NFKB1 gene polymorphisms and the susceptibility to head and neck cancer: a meta-analysis Dis Markers 2019 2019 6523837 10.1155/2019/6523837 Available from: 10.1155/2019/6523837 31612070
119 Li Q Sun J Mohammadtursun N Wu J Dong J Li L Curcumin inhibits cigarette smoke-induced inflammation via modulating the PPARγ-NF-κB signaling pathway Food Funct 2019 10 7983 7994 10.1039/c9fo02159k Available from: 10.1039/c9fo02159k 31773117
120 Li Y He X Lu X Gong Z Li Q Zhang L METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions Nat Commun 2022 13 6350 10.1038/s41467-022-34209-5 Available from: 10.1038/s41467-022-34209-5 36289222
121 Lin KH Ng SC Lu SY Lin YM Lin SH Su TC Diallyl trisulfide (DATS) protects cardiac cells against advanced glycation end-product-induced apoptosis by enhancing FoxO3A-dependent upregulation of miRNA-210 J Nutr Biochem 2024 125 109567 10.1016/j.jnutbio.2024.109567 Available from: 10.1016/j.jnutbio.2024.109567 38185348
122 Lin S Mei W Lai H Li X Weng H Xiong J Cigarette smoking promotes keratinocyte malignancy via generation of cancer stem-like cells J Cancer 2021 12 1085 1093 10.7150/jca.50746 Available from: 10.7150/jca.50746 33442406
123 Liu J Chen SJ Hsu SW Zhang J Li JM Yang DC MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer Theranostics 2021 11 4122 4136 10.7150/thno.53558 Available from: 10.7150/thno.53558 33754052
124 Liu MY Ju YN Jia BW Sun XK Qiu L Liu HY Inhibition of DNA methylation attenuates lung ischemia-reperfusion injury after lung transplantation J Int Med Res 2023 51 2 3000605231153587 10.1177/03000605231153587 Available from: 10.1177/03000605231153587 36756846
125 Long J Tian L Baranova A Cao H Yao Y Rao S Convergent lines of evidence supporting involvement of NFKB1 in schizophrenia Psychiatry Res 2022 312 114588 10.1016/j.psychres.2022.114588 Available from: 10.1016/j.psychres.2022.114588 35524996
126 Lu L Xu H Yang P Xue J Chen C Sun Q Involvement of HIF-1α-regulated miR-21, acting via the Akt/NF-κB pathway, in malignant transformation of HBE cells induced by cigarette smoke extract Toxicol Lett 2018 289 14 21 10.1016/j.toxlet.2018.02.027 Available from: 10.1016/j.toxlet.2018.02.027 29501572
127 Luna P Fernanda Pérez M Castellar-Lopez J Chang A Montoya Y Bustamante J Potential of Angiotensin-(1-7) in COVID-19 Treatment Curr Protein Pept Sci 2023 24 1 89 97 10.2174/1389203724666221130140416 Available from: 10.2174/1389203724666221130140416 36453502
128 Ma J Xu H Wu J Qu C Sun F Xu S Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-κB activation Int Immunopharmacol 2015 29 708 713 10.1016/j.intimp.2015.09.005 Available from: 10.1016/j.intimp.2015.09.005 26432179
129 Ma L Jiang M Zhao X Sun J Pan Q Chu S Cigarette and IL-17A synergistically induce bronchial epithelial-mesenchymal transition via activating IL-17R/NF-κB signaling BMC Pulm Med 2020 20 1 26 10.1186/s12890-020-1057-6 Available from: 10.1186/s12890-020-1057-6 32000730
130 MacLaren G Rage, rage against the dying of the light? Intensive care for the very elderly Minerva Anestesiol 2015 81 709 710 25653149
131 Majumder D Debnath R Nath P Libin Kumar KV Debnath M Tribedi P Bromelain and Olea europaea (L.) leaf extract mediated alleviation of benzo(a)pyrene induced lung cancer through Nrf2 and NFκB pathway Environ Sci Pollut Res Int 2021 28 47306 47326 10.1007/s11356-021-13803-y Available from: 10.1007/s11356-021-13803-y 33893581
132 Malyla V Paudel KR De Rubis G Hansbro NG Hansbro PM Dua K Cigarette smoking induces lung cancer tumorigenesis via upregulation of the WNT/β-catenin signaling pathway Life Sci 2023 326 121787 10.1016/j.lfs.2023.121787 Available from: 10.1016/j.lfs.2023.121787 37209867
133 Marciscano AE Anandasabapathy N The role of dendritic cells in cancer and anti-tumor immunity Semin Immunol 2021 52 101481 10.1016/j.smim.2021.101481 Available from: 10.1016/j.smim.2021.101481 34023170
134 Martey CA Pollock SJ Turner CK O'Reilly KM Baglole CJ Phipps RP Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer Am J Physiol Lung Cell Mol Physiol 2004 287 L981 L991 10.1152/ajplung.00239.2003 Available from: 10.1152/ajplung.00239.2003 15234907
135 Maurer HR Bromelain: biochemistry, pharmacology and medical use Cell Mol Life Sci 2001 58 1234 1245 10.1007/pl00000936 Available from: 10.1007/pl00000936 11577981
136 Medina D Arnold AC Angiotensin-(1-7): Translational avenues in cardiovascular control Am J Hypertens 2019 32 1133 1142 10.1093/ajh/hpz146 Available from: 10.1093/ajh/hpz146 31602467
137 Mei D Liao W Gan PXL Tran QTN Chan C Heng CKM Angiotensin II type-2 receptor activation in alveolar macrophages mediates protection against cigarette smoke-induced chronic obstructive pulmonary disease Pharmacol Res 2022 184 106469 10.1016/j.phrs.2022.106469 Available from: 10.1016/j.phrs.2022.106469 36167278
138 Millet P McCall C Yoza B RelB: an outlier in leukocyte biology J Leukoc Biol 2013 94 941 951 10.1189/jlb.0513305 Available from: 10.1189/jlb.0513305 23922380
139 Min HY Boo HJ Lee HJ Jang HJ Yun HJ Hwang SJ Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation Oncotarget 2016 7 70936 70947 10.18632/oncotarget.12342 Available from: 10.18632/oncotarget.12342 27708216
140 Mockenhaupt K Gonsiewski A Kordula T RelB and neuroinflammation Cells 2021 10 7 1609 10.3390/cells10071609 Available from: 10.3390/cells10071609 34198987
141 Moorthy B Chu C Carlin DJ Polycyclic aromatic hydrocarbons: from metabolism to lung cancer Toxicol Sci 2015 145 5 15 10.1093/toxsci/kfv040 Available from: 10.1093/toxsci/kfv040 25911656
142 Nagah A Amer A Different mechanisms of cigarette smoking-induced lung cancer Acta Biotheor 2021 69 37 52 10.1007/s10441-020-09394-9 Available from: 10.1007/s10441-020-09394-9 32979115
143 Nagah A Amer A Zhang X The effect of cigarette smoking on lung cancer evolution Math Biosci Eng 2019 16 7771 7788 10.3934/mbe.2019390 Available from: 10.3934/mbe.2019390 31698639
144 Navarro HI Liu Y Fraser A Lefaudeux D Chia JJ Vong L RelB-deficient autoinflammatory pathology presents as interferonopathy, but in mice is interferon-independent J Allergy Clin Immunol 2023 152 1261 1272 10.1016/j.jaci.2023.06.024 Available from: 10.1016/j.jaci.2023.06.024 37460023
145 Ou G Zhu M Huang Y Luo W Zhao J Zhang W HSP60 regulates the cigarette smoke-induced activation of TLR4-NF-κB-MyD88 signalling pathway and NLRP3 inflammasome Int Immunopharmacol 2022 103 108445 10.1016/j.intimp.2021.108445 Available from: 10.1016/j.intimp.2021.108445 34998273
146 Owoyele BV Bakare AO Ologe MO Bromelain: a review on its potential as a therapy for the management of Covid-19 Niger J Physiol Sci 2020 35 1 10 19 33084621
147 Pan X Shao Y Wu F Wang Y Xiong R Zheng J FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2/angiotensin-(1-7) axis in mice Cell Metab 2018 27 1323 1337 10.1016/j.cmet.2018.04.002 Available from: 10.1016/j.cmet.2018.04.002 29706566
148 Panchal NK Prince Sabina E Non-steroidal anti-inflammatory drugs (NSAIDs): A current insight into its molecular mechanism eliciting organ toxicities Food Chem Toxicol 2023 172 113598 10.1016/j.fct.2022.113598 Available from: 10.1016/j.fct.2022.113598 36608735
149 Papageorgiou N Zacharia E Briasoulis A Charakida M Tousoulis D Celecoxib for the treatment of atherosclerosis Expert Opin Investig Drugs 2016 25 619 633 10.1517/13543784.2016.1161756 Available from: 10.1517/13543784.2016.1161756
150 Petit P Maître A Persoons R Bicout DJ Lung cancer risk assessment for workers exposed to polycyclic aromatic hydrocarbons in various industries Environ Int 2019 124 109 120 10.1016/j.envint.2018.12.058 Available from: 10.1016/j.envint.2018.12.058 30641254
151 Pitt JM André F Amigorena S Soria JC Eggermont A Kroemer G Dendritic cell-derived exosomes for cancer therapy J Clin Invest 2016 126 1224 1232 10.1172/jci81137 Available from: 10.1172/jci81137 27035813
152 Preciado D Lin J Wuertz B Rose M Cigarette smoke activates NF kappa B and induces Muc5b expression in mouse middle ear cells Laryngoscope 2008 118 464 471 10.1097/MLG.0b013e31815aedc7 Available from: 10.1097/MLG.0b013e31815aedc7 18091336
153 Prijić Ž Igić R Cigarette smoking and medical students J BUON 2021 26 1709 1718 34761573
154 Puccinelli MT Stan SD Dietary bioactive diallyl trisulfide in cancer prevention and treatment Int J Mol Sci 2017 18 8 1645 10.3390/ijms18081645 Available from: 10.3390/ijms18081645 28788092
155 Qian Y Wang W Chen D Zhu Y Wang Y Wang X Cigarette smoking induces the activation of RIP2/caspase-12/NF-κB axis in oral squamous cell carcinoma PeerJ 2022 10 e14330 10.7717/peerj.14330 Available from: 10.7717/peerj.14330 36353608
156 Qiu F Liang CL Liu H Zeng YQ Hou S Huang S Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? Oncotarget 2017 8 1 268 284 10.18632/oncotarget.13613 Available from: 10.18632/oncotarget.13613 27902485
157 Qu Z Tian J Sun J Shi Y Yu J Zhang W Diallyl trisulfide inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer via modulating gut microbiota and the PPARγ/NF-κB pathway Food Funct 2024 15 1 158 171 10.1039/d3fo03914e Available from: 10.1039/d3fo03914e 38086660
158 Rahimi O Melo AC Westwood B Grier RDM Tallant EA Gallagher PE Angiotensin-(1-7) reduces doxorubicin-induced aortic arch dysfunction in male and female juvenile Sprague Dawley rats through pleiotropic mechanisms Peptides 2022 152 170784 10.1016/j.peptides.2022.170784 Available from: 10.1016/j.peptides.2022.170784 35288251
159 Rasmussen KG Rage against the (ECT) machine J ECT 2015 31 1 1 2 10.1097/yct.0000000000000171 Available from: 10.1097/yct.0000000000000171 25181022
160 Rastrick JM Stevenson CS Eltom S Grace M Davies M Kilty I Cigarette smoke induced airway inflammation is independent of NF-κB signalling PLoS One 2013 8 1 e54128 10.1371/journal.pone.0054128 Available from: 10.1371/journal.pone.0054128 23349803
161 Ratovitski EA LKB1/PEA3/ΔNp63 pathway regulates PTGS-2 (COX-2) transcription in lung cancer cells upon cigarette smoke exposure oxidative medicine and cellular longevity 2010 3 878947 10.4161/oxim.3.5.13108 Available from: 10.4161/oxim.3.5.13108
162 Rauf A Abu-Izneid T Thiruvengadam M Imran M Olatunde A Shariati MA Garlic (Allium sativum L.): its chemistry, nutritional composition, toxicity, and anticancer properties Curr Top Med Chem 2022 22 957 972 10.2174/1568026621666211105094939 Available from: 10.2174/1568026621666211105094939 34749610
163 Rioux N Castonguay A The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-kappaB Carcinogenesis 2000 21 1745 1751 10.1093/carcin/21.9.1745 Available from: 10.1093/carcin/21.9.1745 10964107
164 Rivera GA Wakelee H Lung cancer in never smokers Adv Exp Med Biol 2016 893 43 57 10.1007/978-3-319-24223-1_3 Available from: 10.1007/978-3-319-24223-1_3 26667338
165 Rohrer J Wuertz BR Ondrey F Cigarette smoke condensate induces nuclear factor kappa-b activity and proangiogenic growth factors in aerodigestive cells Laryngoscope 2010 120 1609 1613 10.1002/lary.20972 Available from: 10.1002/lary.20972 20564670
166 Rojas-Quintero J Laucho-Contreras ME Wang X Fucci QA Burkett PR Kim SJ CC16 augmentation reduces exaggerated COPD-like disease in Cc16-deficient mice JCI Insight 2023 8 6 e130771 10.1172/jci.insight.130771 Available from: 10.1172/jci.insight.130771 36787195
167 Saba R Halytskyy O Saleem N Oliff IA Buccal Epithelium, cigarette smoking, and lung cancer: review of the literature Oncology 2017 93 347 353 10.1159/000479796 Available from: 10.1159/000479796 28889127
168 Sanders NT Dutson DJ Durrant JW Lewis JB Wilcox SH Winden DR Cigarette smoke extract (CSE) induces RAGE-mediated inflammation in the Ca9-22 gingival carcinoma epithelial cell line Arch Oral Biol 2017 80 95 100 10.1016/j.archoralbio.2017.03.021 Available from: 10.1016/j.archoralbio.2017.03.021 28399471
169 Seet LF Toh LZ Chu SWL Wong TT RelB regulates basal and proinflammatory induction of conjunctival CCL2 Ocul Immunol Inflamm 2021 29 1 29 42 10.1080/09273948.2019.1662060 Available from: 10.1080/09273948.2019.1662060 31618101
170 Shishodia S Aggarwal BB Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9 Cancer Res 2004 64 5004 5012 10.1158/0008-5472.Can-04-0206 Available from: 10.1158/0008-5472.Can-04-0206 15256475
171 Shreves AH Buller ID Chase E Creutzfeldt H Fisher JA Graubard BI Geographic patterns in U.S. lung cancer mortality and cigarette smoking Cancer Epidemiol Biomarkers Prev 2023 32 193 201 10.1158/1055-9965.Epi-22-0253 Available from: 10.1158/1055-9965.Epi-22-0253 36413442
172 Singh A Kamal R Ahamed I Wagh M Bihari V Sathian B PAH exposure-associated lung cancer: an updated meta-analysis Occup Med (Lond) 2018 68 255 261 10.1093/occmed/kqy049 Available from: 10.1093/occmed/kqy049 29579260
173 Singla N Thapa R Kulshrestha R Bhat AA Gupta S Purohit M Gupta G Oliver BG Dua K Ali MK Dave P Introduction to epigenetics Targeting epigenetics in inflammatory lung diseases 2023 Singapore Springer 17 41 10.1007/978-981-99-4780-5_2 Available from: 10.1007/978-981-99-4780-5_2
174 Sivandzade F Prasad S Bhalerao A Cucullo L NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches Redox Biol 2019 21 101059 10.1016/j.redox.2018.11.017 Available from: 10.1016/j.redox.2018.11.017
175 Sokolova O Naumann M NF-κB signaling in gastric cancer Toxins (Basel) 2017 9 4 119 10.3390/toxins9040119 Available from: 10.3390/toxins9040119 28350359
176 Sugano N Shimada K Ito K Murai S Nicotine inhibits the production of inflammatory mediators in u937 cells through modulation of nuclear factor-kB activation Biochem Biophys Res Commun 1998 252 1 25 28 10.1006/bbrc.1998.9599 Available from: 10.1006/bbrc.1998.9599 9813140
177 Sun F Qu Z Xiao Y Zhou J Burns TF Stabile LP NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function Oncogene 2016 35 2299 2310 10.1038/onc.2015.299 Available from: 10.1038/onc.2015.299 26300007
178 Sun SC Non-canonical NF-κB signaling pathway Cell Res 2011 21 1 71 85 10.1038/cr.2010.177 Available from: 10.1038/cr.2010.177 21173796
179 Sun Y Shen W Hu S Lyu Q Wang Q Wei T METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy J Exp Clin Cancer Res 2023 42 1 65 10.1186/s13046-023-02638-9 Available from: 10.1186/s13046-023-02638-9 36932427
180 Thapa R Afzal O Afzal M Gupta G Bhat AA Kazmi I From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression Pathol Res Pract 2024 253 154959 10.1016/j.prp.2023.154959 Available from: 10.1016/j.prp.2023.154959 38029713
181 Thapa R Afzal O Altamimi ASA Goyal A Almalki WH Alzarea SI Galangin as an inflammatory response modulator: An updated overview and therapeutic potential Chem Biol Interact 2023 378 110482 10.1016/j.cbi.2023.110482 Available from: 10.1016/j.cbi.2023.110482 37044286
182 Thapa R Afzal O Bhat AA Goyal A Alfawaz Altamimi AS Almalki WH New horizons in lung cancer management through ATR/CHK1 pathway modulation Future Med Chem 2023 15 1807 1808 10.4155/fmc-2023-0164 Available from: 10.4155/fmc-2023-0164 37877252
183 Thapa R Afzal O Kumar G Bhat AA Almalki WH Alzarea SI Unveiling the connection: long-chain non-coding RNAs and critical signaling pathways in breast cancer Pathol Res Pract 2023 249 154736 10.1016/j.prp.2023.154736 Available from: 10.1016/j.prp.2023.154736 37579591
184 Thapa R Ali H Afzal O Bhat AA Almalki WH Alzarea SI Unlocking the potential of mesoporous silica nanoparticles in breast cancer treatment J Nanopart Res 2023 25 169 10.1007/s11051-023-05813-3 Available from: 10.1007/s11051-023-05813-3
185 Thapa R Goyal A Gupta G Bhat AA Singh SK Subramaniyan V Recent developments in the role of protocatechuic acid in neurodegenerative disorders EXCLI J 2023 22 595 599 10.17179/excli2023-5940 Available from: 10.17179/excli2023-5940 37636028
186 Thapa R Gupta G Bhat AA Almalki WH Alzarea SI Kazmi I A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies Int J Biol Macromol 2023 253 127375 10.1016/j.ijbiomac.2023.127375 Available from: 10.1016/j.ijbiomac.2023.127375 37839597
187 Thapa R Gupta G Dave P Singh SK Raizaday A Almalki WH Current update on the protective effect of epicatechin in neurodegenerative diseases EXCLI J 2022 21 897 903 10.17179/excli2022-5034 Available from: 10.17179/excli2022-5034 36172067
188 Tsurutani J Castillo SS Brognard J Granville CA Zhang C Gills JJ Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells Carcinogenesis 2005 26 1182 1195 10.1093/carcin/bgi072 Available from: 10.1093/carcin/bgi072 15790591
189 Valenca SS Castro P Pimenta WA Lanzetti M Silva SV Barja-Fidalgo C Light cigarette smoke-induced emphysema and NFkappaB activation in mouse lung Int J Exp Pathol 2006 87 373 381 10.1111/j.1365-2613.2006.00492.x Available from: 10.1111/j.1365-2613.2006.00492.x 16965565
190 Walter CEJ Durairajan S Periyandavan K C GPD G DJD A HRV Bladder neoplasms and NF-κB: an unfathomed association Expert Rev Mol Diagn 2020 20 497 508 10.1080/14737159.2020.1743688 Available from: 10.1080/14737159.2020.1743688 32228251
191 Wang H Yin J Guo Y Atorvastatin might resist tobacco smoking-induced endothelial inflammation through the inhibition of NF-κB signal pathway Clin Exp Hypertens 2019 41 1 1 4 10.1080/10641963.2018.1433196 Available from: 10.1080/10641963.2018.1433196 29509049
192 Wang J Tan L Jia B Yu X Yao R N OU Downregulation of m(6)A reader YTHDC2 promotes the proliferation and migration of malignant lung cells via CYLD/NF-κB pathway Int J Biol Sci 2021 17 2633 2651 10.7150/ijbs.58514 Available from: 10.7150/ijbs.58514 34326699
193 Wang J Tang H Duan Y Yang S An J Association between sleep traits and lung cancer: a Mendelian randomization study J Immunol Res 2021 2021 1893882 10.1155/2021/1893882 Available from: 10.1155/2021/1893882 34239941
194 Wang JN Wang F Ke J Li Z Xu CH Yang Q Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms Sci Transl Med 2022 14 640 eabk2709 10.1126/scitranslmed.abk2709 Available from: 10.1126/scitranslmed.abk2709 35417191
195 Wei TT Chandy M Nishiga M Zhang A Kumar KK Thomas D Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation Cell 2022 185 1676 1693 10.1016/j.cell.2022.04.005 Available from: 10.1016/j.cell.2022.04.005 35489334
196 Wibisana JN Okada M Encoding and decoding NF-κB nuclear dynamics Curr Opin Cell Biol 2022 77 102103 10.1016/j.ceb.2022.102103 Available from: 10.1016/j.ceb.2022.102103 35636375
197 Williams LM Gilmore TD Looking down on NF-κB Mol Cell Biol 14 2020 40 15 e00104 e00120 10.1128/MCB.00104-20 Available from: 10.1128/MCB.00104-20 32393609
198 Wronka M Krzemińska J Młynarska E Rysz J Franczyk B The influence of lifestyle and treatment on oxidative stress and inflammation in diabetes Int J Mol Sci 2022 23 24 15743 10.3390/ijms232415743 Available from: 10.3390/ijms232415743 36555387
199 Wu PP Liu KC Huang WW Chueh FS Ko YC Chiu TH Diallyl trisulfide (DATS) inhibits mouse colon tumor in mouse CT-26 cells allograft model in vivo Phytomedicine 2011 18 672 676 10.1016/j.phymed.2011.01.006 Available from: 10.1016/j.phymed.2011.01.006 21315571
200 Xiong WM Xu QP Xiao RD Hu ZJ Cai L He F Genome-wide DNA methylation and RNA expression profiles identified RIPK3 as a differentially methylated gene in Chlamydia pneumoniae infection lung carcinoma patients in China Cancer Manag Res 2019 11 5785 5797 10.2147/cmar.S186217 Available from: 10.2147/cmar.S186217 31388311
201 Yao Y Wu J Quan W Zhou H Zhang Y Wan H Mechanisms of myeloid cell RelA/p65 in cigarette smoking-induced lung cancer growth in mice Zhonghua Zhong Liu Za Zhi 2014 36 412 417 25241781
202 Yin J Wang H Vogel U Wang C Hou W Ma Y Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population Tumour Biol 2016 37 5467 5473 10.1007/s13277-015-4373-3 Available from: 10.1007/s13277-015-4373-3 26563375
203 Yin J Yin M Vogel U Wu Y Yao T Cheng Y NFKB1 common variants and PPP1R13L and CD3EAP in relation to lung cancer risk in a Chinese population Gene 2015 567 1 31 35 10.1016/j.gene.2015.04.059 Available from: 10.1016/j.gene.2015.04.059 25917613
204 Yun Y Gao R Yue H Li G Zhu N Sang N Synergistic effects of particulate matter (PM10) and SO2 on human non-small cell lung cancer A549 via ROS-mediated NF-κB activation J Environ Sci 2015 31 146 153 10.1016/j.jes.2014.09.041 Available from: 10.1016/j.jes.2014.09.041
205 Zago M Rico de Souza A Hecht E Rousseau S Hamid Q Eidelman DH The NF-κB family member RelB regulates microRNA miR-146a to suppress cigarette smoke-induced COX-2 protein expression in lung fibroblasts Toxicol Lett 2014 226 107 116 10.1016/j.toxlet.2014.01.020 Available from: 10.1016/j.toxlet.2014.01.020 24472607
206 Zeng T Zhang CL Zhu ZP Yu LH Zhao XL Xie KQ Diallyl trisulfide (DATS) effectively attenuated oxidative stress-mediated liver injury and hepatic mitochondrial dysfunction in acute ethanol-exposed mice Toxicology 2008 252 1-3 86 91 10.1016/j.tox.2008.07.062 Available from: 10.1016/j.tox.2008.07.062 18755235
207 Zhang Q Lenardo MJ Baltimore D 30 Years of NF-κB: a blossoming of relevance to human pathobiology Cell 2017 168 1-2 37 57 10.1016/j.cell.2016.12.012 Available from: 10.1016/j.cell.2016.12.012 28086098
208 Zhang Y Li Y Shi C Fu X Zhao L Song Y Angiotensin-(1-7)-mediated Mas1 receptor/NF-κB-p65 signaling is involved in a cigarette smoke-induced chronic obstructive pulmonary disease mouse model Environ Toxicol 2018 33 1 5 15 10.1002/tox.22454 Available from: 10.1002/tox.22454 28960804
209 Zhao Y Xu Y Li Y Xu W Luo F Wang B NF-κB-mediated inflammation leading to EMT via miR-200c is involved in cell transformation induced by cigarette smoke extract Toxicol Sci 2013 135 265 276 10.1093/toxsci/kft150 Available from: 10.1093/toxsci/kft150 23824089
